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Abstract: SUMMARY Terminal portions of the nephron, namely the connecting tubule and the collect-
ing duct, are responsible for fine-tuning of acid-base excretion. This is enabled by at least two types of
intercalated cells (IC), type A and B. Acid secretory type A IC expressing vacuolar H+- ATPases on the
apical membrane eliminate protons from the body. On the contrary, base secretory type B IC possessing
vacuolar H+-ATPases on the basolateral membrane reabsorb protons during metabolic alkalosis. Vacuo-
lar H+-ATPases are composed of several subunits. Among them, the B1 subunit has been shown to be
important for normal final urinary acidification in man. The generation of B1 subunit deficient mouse
model has enabled the examination of the role of this subunit for normal IC function as well as the inter-
action of proton transport with other transport processes. In the first series of experiments, we focused on
functional interaction between sodium reabsorption and proton secretion in the connecting tubule (CNT)
and collecting duct (CD). It has been hypothesised that electrogenic sodium reabsorption via epithelial
sodium channels (ENaCs) in the apical membrane of principal cells may promote H+-ATPase-mediated
proton secretion by neighbouring ICs by creating a more lumen-negative voltage. Furosemide-induced
increases in sodium delivery to the CNT and CCD enhanced urinary acidification and net acid excretion
in wild type mice. The effect of furosemide was abolished with amiloride or benzamil, blocking ENaC ac-
tion. In mice deficient in the kidney-specific vacuolar H+-ATPase B1 subunit, furosemide led to minimal
urinary acidification. In contrast, furosemide treatment alone and in combination with hydrochloroth-
iazide in mice with a kidney-specific inactivation of the ￿ subunit of ENaC in the CCD and MCD, but not
in the CNT, led to normal urinary acidification. These results suggest that the B1 subunit of the vacuolar
H+-ATPase is necessary for furosemideinduced acute urinary acidification. Loss of ENaC channels in the
CCD and MCD did not affect this acidification. Thus, functional expression of ENaC channels in the
CNT is sufficient for furosemide-stimulated urinary acidification and identifies the CNT as a major seg-
ment in electrogenic urinary acidification. In a second series, we investigated the contribution of the B1
subunit to normal type B IC function. The relative abundance of these cells is increased during metabolic
alkalosis since they are specialized in bicarbonate secretion via the apical Cl-/HCO3 - exchanger, pen-
drin, and proton reabsorption via basolateral vacuolar H+-ATPases. Induction of metabolic alkalosis
with deoxycorticosterone acetate (DOCA) and NaHCO3 resulted in a more pronounced alkalosis in B1
deficient mice. The observed alkalosis was associated with increased serum bicarbonate, hypokalemia,
and hypochloremia. Furthermore, B1 deficient mice showed decreased total pendrin expression whereas
the relative abundance of pendrin expressing cells was increased. H+-ATPase activity in intercalated
cells of isolated CCD was strongly reduced, demonstrating that B1 containing H+-ATPases are essential
for normal type B intercalated cell function. Furthermore, B1 deficient mice excreted larger quantities
of urine which was associated with lower AQP- 2 water channel abundance and a higher relative fre-
quency of principal cells in the connecting tubule. Thus, the B1 subunit of the H+-ATPase is required
for normal B-type IC function and its absence may also affect principal cell function. The role of the B1
subunit in bicarbonate secretion and water reabsorption have been hitherto not fully recognized and may
also affect renal function in patients with ATP6V1B1 mutations. DEUTSCHE ZUSAMMENFASSUNG
DER DOKTORARBEIT Die terminalen Nephronsegmente, d.h. das Verbindungsstück und das Sam-
melrohr, sind verantwortlich für die Feineinstellung der Säure- Basen-Ausscheidung. Mindestens zwei
Typen von Schaltzellen existieren, Typ A und B, die diese Ausscheidung ermöglichen. Säureausschei-
dende A-Schaltzellen besitzen eine apikale H+-ATPase, durch die die Protonen eliminiert werden. Im
Gegensatz zu den A-Schaltzellen besitzen die B-Schaltzellen eine basolaterale H+-ATPase, durch die die
Protonen während einer metabolischen Alkalose reabsorbiert werden. Vakuoläre H+-ATPasen bestehen
aus mindestens 13 Untereinheiten. Eine von ihnen ist die B1- Untereinheit, die eine entscheidende Rolle
für die finale Urinansäuerung im Menschen spielt. Der genetische Knock-out der B1-Untereinheit in
Mäusen ermöglichte es, die Rolle dieser Untereinheit für die normale Schaltzellenfunktion und die In-
teraktion zwischen dem Protonentransport und anderen Transportprozessen zu untersuchen. Die ersten
Experimente konzentrierten sich auf die funktionelle Interaktion zwischen der Natriumreabsorption und
der Protonenausscheidung im Verbindungsstück und im Sammelrohr. In diesen Nephronsegmenten wird
Natrium durch den epithelialen Na+- Kanal (ENaC) in der apikalen Membran der Hauptzellen resor-
biert. Da diese Natriumreabsorption elektrogen ist, entsteht ein lumennegatives transzelluläres Potenzial,
welches die Protonensekretion durch die H+-ATPase von den benachbarten Schaltzellen antreibt. Die
durch das Diuretikum Furosemid erhöhte Natriumabgabe in das Verbindungsstück und in das Sammelrohr
fördert die Urinansäuerung und die Netto- Säureausscheidung in normalen Wildtypmäusen. Blockade
des ENaC Natriumkanals mit Amilorid und Benzamil hebt diese Wirkung von Furosemid auf. In den
Mäusen ohne die B1- Untereinheit der vakuolären H+-ATPase, verursachte Furosemid nur eine min-
imale Urinansäuerung. In Mäusen mit der nierenspezifisch inaktivierten ￿-Untereinheit des ENaC im
kortikalen und medullären Sammelrohr – jedoch nicht im Verbindungsstück – wurde jedoch nach einer
Behandlung mit entweder Furosemid alleine, oder zusammen mit Hydrochlorothiazid, eine normale Uri-
nansäuerung beobachtet. Diese Resultate deuten darauf hin, dass die B1-Untereinheit der vakuolären
H+- ATPase für die akute, durch Furosemid induzierte Urinansäuerung notwendig ist. Der Verlust
von ENaC-Kanälen im kortikalen und medullären Sammelrohr beeinflusst die Ansäuerung nicht. Die
Expression von ENaC-Kanälen im Verbindungsstück ist für die Furosemid-stimulierte Urinansäuerung
ausreichend. Das Verbindungsstück wird damit als das Hauptsegment der elektrogenen Urinansäuerung
identifiziert. Im zweiten Teil dieser Arbeit wurde der Einfluss der B1- Untereinheit auf die die normale
B-Schaltzellenfunktion untersucht. Da dieser Typ von Schaltzellen auf die Bikarbonatsekretion durch
den apikalen Cl- /HCO3 –Austauscher, Pendrin, und die Protonenreabsorption durch die basolaterale
H+-ATPase spezialisiert sind, wird ihre relative Häufigkeit während einer metabolischen Alkalose erhöht.
Durch Induzierung einer metabolischen Alkalose mit Deoxykortikosteronazetat (DOCA) und NaHCO3,
wurde in den B1-defizienten Mäusen eine ausgeprägte Alkalose verursacht, die durch einen erhöhten
Serumbikarbonatwert, einer Hypokaliämie und einer Hypochlorämie charakterisiert war. Ausserdem
zeigten B1-defiziente Mäuse eine gesamthafte Verminderung der Pendrin-Expression, während die relative
Häufigkeit von pendrinexprimierenden Zellen anstieg. Die Aktivität der H+- ATPase in B-Schaltzellen
war stark reduziert, was darauf hinweist, dass die H+-ATPasen, die B1-Untereinheit beinhalten, für
eine normale Funktion der B-Schaltzellen essentiell sind. B1-defiziente Mäuse schieden zudem grössere
Mengen Urin aus, was mit einer niedrigeren Anzahl an AQP2-Kanälen und mit einer höheren relativen
Häufigkeit von Hauptzellen im Verbindungsrohr assoziiert war. Demnach ist die B1- Untereinheit der
H+-ATPase notwendig für eine normale B-Schaltzellenfunktion, und ihr Fehlen kann auch die Funktion
der Hauptzellen beeinträchtigen. Die Rolle der B1- Untereinheit in der Bikarbonatsekretion und in der
Wasserreabsorption ist bis jetzt nicht vollständig verstanden und und die Ergebnisse dieser Arbeit können
auch zum Verständnis der Pathophysiologie bei Patienten mit einer Mutation in ATP6V1B1 beitragen.
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SUMMARY 
 
Terminal portions of the nephron, namely the connecting tubule 
and the collecting duct, are responsible for fine-tuning of acid-base excretion. 
This is enabled by at least two types of intercalated cells (IC), type A and B. 
Acid secretory type A IC expressing vacuolar H+-ATPases on the apical 
membrane eliminate protons from the body. On the contrary, base secretory 
type B IC possessing vacuolar H+-ATPases on the basolateral membrane 
reabsorb protons during metabolic alkalosis. Vacuolar H+-ATPases are 
composed of several subunits. Among them, the B1 subunit has been shown 
to be important for normal final urinary acidification in man. 
The generation of B1 subunit deficient mouse model has 
enabled the examination of the role of this subunit for normal IC function as 
well as the interaction of proton transport with other transport processes.          
In the first series of experiments, we focused on functional 
interaction between sodium reabsorption and proton secretion in the 
connecting tubule (CNT) and collecting duct (CD). It has been hypothesised 
that electrogenic sodium reabsorption via epithelial sodium channels (ENaCs) 
in the apical membrane of principal cells may promote H+-ATPase-mediated 
proton secretion by neighbouring ICs by creating a more lumen-negative 
voltage. Furosemide-induced increases in sodium delivery to the CNT and 
CCD enhanced urinary acidification and net acid excretion in wild type mice. 
The effect of furosemide was abolished with amiloride or benzamil, blocking 
ENaC action. In mice deficient in the kidney-specific vacuolar H+-ATPase B1 
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subunit, furosemide led to minimal urinary acidification. In contrast, furosemide 
treatment alone and in combination with hydrochlorothiazide in mice with a 
kidney-specific inactivation of the α subunit of ENaC in the CCD and MCD, but 
not in the CNT, led to normal urinary acidification. These results suggest that 
the B1 subunit of the vacuolar H+-ATPase is necessary for furosemide-
induced acute urinary acidification. Loss of ENaC channels in the CCD and 
MCD did not affect this acidification. Thus, functional expression of ENaC 
channels in the CNT is sufficient for furosemide-stimulated urinary acidification 
and identifies the CNT as a major segment in electrogenic urinary acidification. 
In a second series, we investigated the contribution of the B1 
subunit to normal type B IC function. The relative abundance of these cells is 
increased during metabolic alkalosis since they are specialized in bicarbonate 
secretion via the apical Cl-/HCO3- exchanger, pendrin, and proton reabsorption 
via basolateral vacuolar H+-ATPases. Induction of metabolic alkalosis with 
deoxycorticosterone acetate (DOCA) and NaHCO3 resulted in a more 
pronounced alkalosis in B1 deficient mice. The observed alkalosis was 
associated with increased serum bicarbonate, hypokalemia, and 
hypochloremia. Furthermore, B1 deficient mice showed decreased total 
pendrin expression whereas the relative abundance of pendrin expressing 
cells was increased. H+-ATPase activity in intercalated cells of isolated CCD 
was strongly reduced, demonstrating that B1 containing H+-ATPases are 
essential for normal type B intercalated cell function. Furthermore, B1 deficient 
mice excreted larger quantities of urine which was associated with lower AQP-
2 water channel abundance and a higher relative frequency of principal cells in 
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the connecting tubule. Thus, the B1 subunit of the H+-ATPase is required for 
normal B-type IC function and its absence may also affect principal cell 
function. The role of the B1 subunit in bicarbonate secretion and water 
reabsorption have been hitherto not fully recognized and may also affect renal 
function in patients with ATP6V1B1 mutations. 
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DEUTSCHE ZUSAMMENFASSUNG DER DOKTORARBEIT 
 
Die terminalen Nephronsegmente, d.h. das Verbindungsstück 
und das Sammelrohr, sind verantwortlich für die Feineinstellung der Säure-
Basen-Ausscheidung. Mindestens zwei Typen von Schaltzellen existieren, Typ 
A und B, die diese Ausscheidung ermöglichen. Säureausscheidende A-
Schaltzellen besitzen eine apikale H+-ATPase, durch die die Protonen 
eliminiert werden.  Im Gegensatz zu den A-Schaltzellen besitzen die B- 
Schaltzellen eine basolaterale H+-ATPase, durch die die Protonen während 
einer metabolischen Alkalose reabsorbiert werden. Vakuoläre H+-ATPasen 
bestehen aus mindestens 13 Untereinheiten. Eine von ihnen ist die B1-
Untereinheit, die eine entscheidende Rolle für die finale Urinansäuerung im 
Menschen spielt. 
Der genetische Knock-out der B1-Untereinheit in Mäusen  
ermöglichte es, die Rolle dieser Untereinheit für die normale 
Schaltzellenfunktion und die Interaktion zwischen dem Protonentransport und 
anderen Transportprozessen zu untersuchen. 
Die ersten Experimente konzentrierten sich auf die funktionelle 
Interaktion zwischen der Natriumreabsorption und der Protonenausscheidung 
im Verbindungsstück und im Sammelrohr.  In diesen Nephronsegmenten wird 
Natrium durch den epithelialen Na+-Kanal (ENaC) in der apikalen Membran 
der Hauptzellen resorbiert. Da diese Natriumreabsorption elektrogen ist, 
entsteht ein lumennegatives transzelluläres Potenzial, welches die 
Protonensekretion durch die H+-ATPase von den benachbarten Schaltzellen 
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antreibt. Die durch das Diuretikum Furosemid erhöhte Natriumabgabe in das 
Verbindungsstück und in das Sammelrohr fördert die Urinansäuerung und die 
Netto- Säureausscheidung in normalen Wildtypmäusen. Blockade des ENaC 
Natriumkanals mit Amilorid und Benzamil hebt diese Wirkung von  Furosemid 
auf. In den Mäusen ohne die B1-Untereinheit der vakuolären H+-ATPase, 
verursachte Furosemid nur eine minimale Urinansäuerung. In Mäusen mit der 
nierenspezifisch inaktivierten α-Untereinheit des ENaC im kortikalen und 
medullären Sammelrohr – jedoch nicht im Verbindungsstück – wurde jedoch 
nach einer Behandlung mit entweder Furosemid alleine, oder zusammen mit 
Hydrochlorothiazid, eine normale Urinansäuerung beobachtet. Diese 
Resultate deuten darauf hin, dass die B1-Untereinheit der vakuolären H+-
ATPase für die akute, durch Furosemid induzierte Urinansäuerung notwendig 
ist. Der Verlust von ENaC-Kanälen im kortikalen und medullären Sammelrohr 
beeinflusst die Ansäuerung nicht. Die Expression von ENaC-Kanälen im 
Verbindungsstück ist für die Furosemid-stimulierte Urinansäuerung 
ausreichend. Das Verbindungsstück wird damit als das Hauptsegment der 
elektrogenen Urinansäuerung identifiziert. 
Im zweiten Teil dieser Arbeit wurde der Einfluss der B1-
Untereinheit auf die die normale B-Schaltzellenfunktion untersucht. Da dieser 
Typ von Schaltzellen auf die Bikarbonatsekretion durch den apikalen Cl-
/HCO3--Austauscher, Pendrin, und die Protonenreabsorption durch die 
basolaterale H+-ATPase spezialisiert sind, wird ihre relative Häufigkeit 
während einer metabolischen Alkalose erhöht. Durch Induzierung einer 
metabolischen Alkalose mit Deoxykortikosteronazetat (DOCA) und NaHCO3, 
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wurde in den B1-defizienten Mäusen eine ausgeprägte Alkalose verursacht, 
die durch einen erhöhten Serumbikarbonatwert, einer Hypokaliämie und einer 
Hypochlorämie charakterisiert war. Ausserdem zeigten B1-defiziente Mäuse 
eine gesamthafte Verminderung der Pendrin-Expression, während die relative 
Häufigkeit von pendrinexprimierenden Zellen anstieg. Die Aktivität der H+-
ATPase in B-Schaltzellen war stark reduziert, was darauf hinweist, dass die 
H+-ATPasen, die B1-Untereinheit beinhalten, für eine normale Funktion der B-
Schaltzellen essentiell sind. B1-defiziente Mäuse schieden zudem grössere 
Mengen Urin aus, was mit einer niedrigeren Anzahl an AQP2-Kanälen und mit 
einer höheren relativen Häufigkeit von Hauptzellen im Verbindungsrohr 
assoziiert war. Demnach ist die B1-Untereinheit der H+-ATPase notwendig für 
eine normale B-Schaltzellenfunktion, und ihr Fehlen kann auch die Funktion 
der Hauptzellen beeinträchtigen. Die Rolle der B1-Untereinheit in der 
Bikarbonatsekretion und in der Wasserreabsorption ist bis jetzt nicht 
vollständig verstanden und und die Ergebnisse dieser Arbeit können auch zum 
Verständnis der Pathophysiologie bei Patienten mit einer Mutation in 
ATP6V1B1 beitragen. 
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1. INTRODUCTION 
 
Systemic pH must be maintained at the physiological level of 7.4 
to assure normal function of the body. This is achieved by interactions 
between the body’s buffering systems; the lungs and the kidneys. Apart from 
CO2 levels in the blood, a potential acid which is removed by exhalation, 
metabolism and food intake generate also non-volatile acids and bases. A 
person weighing 70 kg and ingesting typical western protein-rich diet produces 
approximately 70 mmole of H+ daily, which must be excreted by the kidney. 
The kidneys handle this acid-load by ‘’dividing’’ 70 mmole/day of H2CO3 
excreting approximately 70 mmole/day H+ into the urine and simultaneously 
transporting 70 mmole/day of new HCO3- into the blood. Apart from that, the 
kidneys are also reclaiming virtually all HCO3- filtered by the glomeruli from the 
tubule fluid. The largest fraction of HCO3- is reabsorbed in the proximal tubule 
(~ 80%) and the thick ascending limb of the loop of Henle (~ 20 %). The 
connecting tubule (CNT) and the collecting duct (CD), the terminal portions of 
the nephron (Fig. 1A), are ultimately responsible for the fine-tuning of urine pH 
by reabsorbing approximately 2% of filtered bicarbonate and simultaneously 
secreting protons.  
The epithelium of CNT and CD possess IC which specialize in 
acid-base transport. At least two types of intercalated cells have been 
described: type A and B (Fig. 1B). Acid secretory type A cells express 
vacuolar H+-ATPases on the apical membrane and the Cl-/HCO3- exchanger 
AE1 on the basolateral membrane. Type B IC secrete bicarbonate via the 
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apical Cl-/HCO3- exchanger pendrin and reabsorb protons via vacuolar H+-
ATPases expressed on the basolateral membrane, and therefore play a 
crucial role during metabolic alkalosis (79). 
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Fig. 1. Model of nephron (A) and IC (B).  
CNT – connecting tubule; CCD – cortical collecting duct; OMCD – outer medullary 
collecting duct; IMCD – inner medullary collecting duct; IC – intercalated cells. 
 
 
 
The vacuolar H+-ATPase is composed of 13 distinct subunits 
forming V0 and V1 domains. The cytosolic V1 domain hydrolyses ATP which 
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provides energy for proton extrusion through the transmembrane, V0 domain. 
One of the V1 domain subunits is also the B subunit existing in the B1 and B2 
isoforms. Whereas the B2 subunit is ubiquitously expressed, the B1 subunit 
has been found only in a limited numbers of tissues such as the kidneys, testis 
and inner ear (77). In man, mutations in the gene encoding for the B1 subunit 
result in distal renal tubular acidosis (43), a disease when distal nephron fails 
to excrete acid leading to the development of metabolic acidosis in the setting 
of otherwise normal renal function (23).       
The generation of a B1 subunit-deficient mouse (32)  has made it 
possible to study the contribution of this subunit to normal H+-ATPase function 
in type A and B IC and additionally to investigate the interaction of proton 
secretion with other transport processes.  
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2. ACID-BASE TRANSPORT IN THE COLLECTING DUCT 
 
The collecting duct, located in the terminal portion of the 
nephron, is a heterogeneous epithelium involved in the control of acid-base 
status, sodium-potassium balance and water homeostasis. It comprises 
several segments such as the connecting tubule (CNT), cortical collecting duct 
(CCD), outer medullary collecting duct (OMCD) and inner medullary collecting 
duct (IMCD) all of which consist of two types of cells; principal cells (PC) (also 
called segment specific cells) and intercalated cells (IC).  
Principal cells specialize in water reabsorption mediated by 
apical AQP2 and also maintain sodium and potassium homeostasis. This is 
enabled by sodium reabsorption through the epithelial sodium channel ENaC 
residing on the apical membrane and potassium secretion through the ROMK 
channel (Renal Outer Medullary K channel). In the CNT and CCD, sodium 
reabsorption generates a lumen-negative voltage of -5 to -40 mV favouring 
potassium and proton secretion (19, 83). In the OMCD and IMCD negligible 
sodium reabsorption occurs so that the subsequent H+-secretion is Na+-
independent, and as a result, the lumen potential becomes positive (84, 85). 
Intercalated cells, accounting for approximately 40% of cells in 
the collecting duct, are involved in acid-base homeostasis. Based on their 
morphological and functional features at least two types of intercalated cells 
have been distinguished: type A and type B IC. Type A IC express anion 
exchanger AE1 on the basolateral membrane and vacuolar H+-ATPases on 
the apical membrane, thus allowing for proton secretion and bicarbonate 
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reabsorption. In the cytosol of these cells, carbonic anhydrase II (CAII) 
catalyzes the hydration of CO2, generating H+ and HCO3-. Bicarbonate is 
extruded through the basolateral membrane via the Cl-/HCO3- -exchanger AE1 
while protons are secreted through vacuolar H+-ATPases (and a negligible 
portion through H+/K+-ATPases) located on the apical membrane. In the 
lumen, protons bind to HCO3- ions generating H2CO3, which in turn are 
converted to CO2 and H2O. CO2 may diffuse back into the cell to replenish the 
substrate for CAII, allowing the cycle to continue. Urinary HCO3- losses are 
thus minimized by this titration. Protons secreted into the lumen are also 
titrated by other buffers such as ammonia and phosphate leading to the further 
enhancement of proton secretion. Type A IC can be found in CNT, CCD, 
OMCD and in initial part of IMCD (46, 73) and are virtually absent in the 
terminal two-thirds of the IMCD (14). Type B IC reverse the polarity of A IC, 
and thus mediate bicarbonate secretion and proton reabsorption. In these cells 
bicarbonate secretion is enabled via pendrin, which is also used as a specific 
marker of type B IC localized on the apical membrane (64). Proton 
reabsorption is achieved by the action of vacuolar H+-ATPases expressed on 
the basolateral membrane. Thus, type B IC, found in CNT and CCD play an 
essential role particularly during metabolic alkalosis (66) by conserving 
protons and excreting bicarbonate. 
It has been shown that the induction of acidosis or alkalosis 
produces changes in relative abundance of different IC subtypes (6, 13, 66, 
78). In addition, the existence of the third type of IC, so-called non-A, non-B 
cells have been reported. These cells express pendrin on the apical 
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membrane, similar to type B IC, and also express H+-ATPases on the apical 
membrane like that of type A IC (46, 73, 80). They are found in the CNT and 
CCD and are therefore considered a possible intermediate state between the 
type A and B IC. This quality is termed ‘’intercalated cell plasticity’’ (reviewed 
in (2). In cell culture, some investigators (27) observed the conversion of type 
B IC to type A IC as well as to PC and suggest the B IC as a ‘’stem’’ cell (27). 
Other studies have reported that the B cells, following an intracellular acid-
load, reversed their apical Cl-/HCO3- activity to the basolateral Cl-/HCO3- 
activity (53); (26). However, there is lack of evidence that interconversion 
between the different cell types occurs in vivo.    
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3. RENAL VACUOLAR H+-ATPase 
 
Vacuolar H+-ATPases are multisubunit proteins which utilize the 
energy stemming from ATP hydrolysis to transport protons across 
membranes. They belong to the superfamily of ATPases that are divided into 
three subclasses: 1) P-type ATPases such as Na+-K+-ATPases, Ca2+-
ATPases, and H+-K+-ATPases; 2) mitochondrial F1F0-ATPases; and 3) V-type 
(vacuolar) H+-ATPases (56).  
Vacuolar H+-ATPases are expressed in virtually all cells. They 
are found in the membranes of intracellular organelles such as lysosomes, the 
Golgi apparatus, secretory vesicles, and endosomes. Their role is to acidify 
the intracellular compartment, creating an  optimal pH environment for enzyme 
function (71). In some tissues they are expressed also in the plasma 
membrane and mediate proton extrusion from the cell, thus contributing to the 
specialized function of the tissue. In osteoclasts, protons transported by 
vacuolar H+-ATPase serve to dissolve bone matrix (74). In the inner ear they 
secrete protons into endolymph (21, 29, 69) and in the epididymis they acidify 
luminal fluid which is necessary for sperm maturation (11).  In the kidney 
vacuolar H+-ATPases are involved in acid-base transport, thus contributing to 
overall body homeostasis.  
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3.1.  Structure of the vacuolar H+-ATPase 
 
Vacuolar H+-ATPases consist of two domains, a cytosolic 
catalytic V1 domain (640 kDa) and a transmembrane V0 domain (240 kDa), 
together forming a protein complex of 900 kDa (36, 58) (Fig. 2). The V0 
domain is composed of 5 subunits termed a, c, c’, c’’ and d (61) which  form a 
proton-translocating pore. The a subunit, existing in 4 isoforms,  is suggested 
to be important for assembly and function of the H+-ATPase (45, 48). 
Mutations in the kidney specific a4 isoform cause distal renal tubular acidosis 
(42). 
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Fig. 2. Structural model of the vacuolar H+-ATPase 
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 The cytosolic V1 domain hydrolyzes ATP, providing energy for 
active proton transport. It is composed of 8 subunits categorized as A-H 
present in the stoichiometry of A3:B3:C:D:E2:F:G2:H (58). Previous work with 
yeast revealed that the B subunit is crucial for vacuolar H+-ATPase function. 
Mutants with the disrupted gene encoding the B subunit result in a lethal 
phenotype unless grown in media with a narrow acidity range around pH 5.5 
(57, 89). The B subunit exists in two isoforms, namely B1 and B2, differing in 
their carboxy termini raising the possibility that they are fulfilling different 
functions (59, 62). The carboxy terminus of the B1 subunit, but not the B2 
subunit, possesses a PDZ domain which can interact with other PDZ 
proteins.(12). Thus, the PDZ domain may enable the interactions of the B1 
subunit with other proteins which could mediate trafficking or regulation of the 
B1 subunit containing H+-ATPases (12). Furthermore, mutations in the B1 
subunit have been shown to cause inherited distal renal tubular acidosis (43). 
 
 
  3.2. Vacuolar H+-ATPase in the kidney 
 
The vacuolar H+-ATPase was shown by immunohistochemistry 
to be localized in the microvilli of the proximal tubule brush border, in the 
apical and basolateral membranes of the initial segment of the thin descending 
limb, and in the apical plasma membranes of thick ascending limb, in distal 
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tubule, connecting tubule and collecting duct (14) with the highest levels in the 
proximal tubule and intercalated cells of the collecting duct.  
In the proximal tubule protons are excreted mainly by the action 
of Na+/H+ exchangers, especially by the NHE-3 isoform (20); (81). Up to 40% 
of proximal tubule proton secretion appears to be mediated by the vacuolar 
H+-ATPase expressed in the brush border membrane (18, 81).  
In the collecting duct, the vacuolar H+-ATPase is the main 
transporter mediating proton secretion. Intercalated cells of the collecting duct 
showed apical, basolateral, diffuse or even bipolar patterns of H+-ATPase 
distribution (8, 13). Vacuolar H+-ATPase residing on the apical membrane of A 
IC is involved in the proton extrusion into the lumen, which is coupled to the 
bicarbonate reabsorption via the anion exchanger AE1 on the basolateral 
membrane. B IC expressing H+-ATPases on the basolateral membrane and 
the anion exchanger pendrin on the apical membrane reverse this process 
and are activated during metabolic alkalosis (33, 51).  In the CCD, all subtypes 
of IC are detectable. In the outer stripe of the outer medulla, A-cells 
predominate, but a few residual B-cells can be found. In the inner stripe of the 
outer medulla, only A-IC are present. In the inner medulla, the epithelium 
initially contains between 5 and 10% A-IC, and these cells disappear from the 
epithelium in the middle and terminal portions of the inner medullary collecting 
duct (14).   
In addition to vacuolar H+-ATPases, a H+-K+-ATPase has been 
found in the outer medullary collecting duct (28, 86, 87). It has, however, 
emerged that its contribution to overall proton secretion in this segment is 
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minor and that H+-K+-ATPases may rather play an important role as a 
potassium scavenging pathway during systemic potassium depletion (25, 35).  
 
 
3.2.1. Role of the B1 vacuolar H+-ATPase subunit in the kidney       
  
The B subunit is a part of the cytosolic V1 domain and exists in 
two isoforms: B1 and B2 (75); (31). Whereas the B2 subunit is considered to 
be ubiquitous and mediates the acidification of intracellular organelles, the B1 
subunit has been identified only in a limited number of tissues. The B1 subunit 
has been detected in epidydimis (11, 15, 70), the vas deferens (11), the ciliar 
body of the eye (82), in the inner ear (43, 69), the lung (54) and in intercalated 
cells of the kidney (59). 
Recently one study (60) demonstrated the expression of the 
ubiquitous B2 subunit along the nephron, including A and B IC. Under 
baseline conditions the B2 subunit was predominantly seen in the cytosol. 
However, under conditions that require insertion of the H+-ATPase into the 
membrane, such as chronic carbonic anhydrase inhibition, the B2 subunit was 
also detected in the apical membrane of of A IC. In contrast, basolateral 
expression of B2 subunit in B-IC was weak or not observed. Thus, basolateral 
targeting of the B2 subunit in B-IC may be less efficient (60). 
This distinct pattern of B isoforms distribution might be explained 
by a different structure of their carboxy termini. The B1 subunit, but not the B2 
subunit, possesses a PDZ domain what is known to interact with other PDZ 
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proteins. These PDZ protein-protein interactions could be involved in the 
targeting or trafficking of the H+-ATPase (12). It was demonstrated that the 
PDZ protein NHE-RF1 colocalizes with the B1 subunit in the membrane of B 
IC. However NHE-RF1 was not detected in A IC. This indicates that NHE-RF1 
is required for basolateral targeting (12) and therefore the PDZ domain lacking 
B2 subunit may not be able to reach the basolateral membrane of B IC (60).  
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4. REGULATION OF RENAL VACUOLAR H+-ATPase 
 
4.1. Adaptive regulation 
 
In the kidney, proton secretion by intercalated cells is regulated 
to a great extent by modulating the amount of vacuolar H+-ATPase at the cell 
surface. Vacuolar H+-ATPase proteins are shuttled to and from the apical 
membrane via specialized intracellular acidic vesicles (2, 8). It has been 
shown that in systemic acidosis the number of cortical intercalated cells with 
apical membrane vacuolar H+-ATPase expression increases and the number 
of cells with basolateral vacuolar H+-ATPase expression decreases (8, 70). 
Conversely, in systemic alkalosis, the number of cells with basolateral 
vacuolar H+-ATPase expression increases, whereas apical vacuolar H+-
ATPase expression decreases (8, 70). 
 
 
4.2. Hormonal regulation 
 
Vacuolar H+-ATPases are strongly regulated by the renin-
angiotensin-aldosterone system. This system is especially known for its effect 
on sodium homeostasis and blood pressure regulation but has also influence 
on the renal handling of acid and bases..  
Angiotensin II is formed in two steps from angiotensinogen. In 
the first step angiotensinogen is activated by the protease renin to 
19
 
angiotensin I, which is then converted to angiotensin II by the angiotensin 
converting enzyme (ACE) in the second step. Angiotensin II binds to two 
receptor subtypes, AT1 being activated by picomolar angiotensin II 
concentrations and AT2 activated by (high) nanomolar concentrations (5). AT1 
was found in vessels and along the entire nephron (4). Activation of the AT1 
receptor triggers the events that lead to the increase in blood pressure, such 
as vasoconstriction and increase in  Na+, HCO3–, and fluid reabsorption (4). 
Sodium and bicarbonate reabsorption as well as proton secretion are achieved 
by AT1 receptor activation and subsequent stimulation of Na+/HCO3– 
cotransporter, NHE-3 and the vacuolar H+-ATPase (34); (63). The AT2 
receptor is also expressed in the kidney and seems to antagonize the effects 
of the AT1.  
Aldosterone is synthesized and released from adrenal glands in 
response to several stimuli such as angiotensin II, hypokalemia, or metabolic 
acidosis. It serves primarily to enhance Na+ reabsorption in kidney and colon, 
thereby regulating extracellular volume and blood pressure (76). The action of 
aldosterone is classically mediated by altering transcription of target genes 
after binding to the mineralocorticoid receptor. In the kidney, mineralocorticoid 
receptors are expressed along the entire length of the connecting segment 
and collecting duct (49). Activation of these receptors results in changes of 
transcription/translation of target proteins. These changes can occur either 
early (within 30 min) or up to several hours (early genes), or alternatively start 
only after several hours (late genes). Apart from this genomic effect 
aldosterone also has nongenomic effects (76); (50). 
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In the collecting duct aldosterone is enhancing proton secretion 
via vacuolar H+-ATPase by at least three distinct mechanisms: 1) Stimulation 
of electrogenic Na+ reabsorption through the luminal epithelial Na+ channel 
(76)) resulting in lumen-negative potential, which increases the electrical 
driving force for H+ secretion in the cortical collecting duct (37). 2) A direct 
action on H+ secretion via transcriptional/translational pathways that has been 
shown in turtle bladder and in rat medullary collecting duct (3, 24).  3) 
Trafficking of H+-ATPase to the membrane (88), a rapid nongenomic effect 
that cannot be prevented by the mineralocorticoid receptor blocker 
spironolactone. On the contrary, this effect can be inhibited by the colchicine 
induced disruption of microtubules. In addition, inhibition of protein kinase C-
dependent processes with chelerythrine abolished the stimulatory effect of 
aldosterone, pointing to a role of protein kinase C in this signaling cascade 
(88).  
Other hormones involved in regulation of acid-base transport are 
thyroid hormones (55), endothelin, kallikrein, calcitonin and vasopressin (77).   
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5.  DISTAL RENAL TUBULAR ACIDOSIS 
 
Primary distal renal tubular acidosis (dRTA) arises when the 
collecting duct fails to remove excess acid into the urine. It is characterized by 
the failure of the kidney to produce acid urine appropriately in the presence of 
systemic metabolic acidosis in the setting of otherwise normal renal function 
(23). If the metabolic acidosis is compensated such that arterial pH is within 
normal limits, dRTA can be diagnosed by demonstrating the failure of urinary 
acidification after oral ammonium chloride administration. However, 
investigators also use furosemide (9), causing increased distal sodium delivery 
that also results in urine acidification (and kaliuresis) under normal 
circumstances.  
Failure to appropriately excrete the normal nonvolatile acid 
products of the diet in dRTA results in hypokaliemic hyperchloremic metabolic 
acidosis of varying severity. Primary dRTA is almost always accompanied by 
variably severe nephrocalcinosis and/or nephrolithiasis associated with 
hypercalciuria. Urinary citrate is low because citrate reabsorption is 
upregulated in the proximal tubule to provide new bicarbonate (1 citrate = 2 
bicarbonate). Abnormal calcium deposition in dRTA is attributed largely both to 
this hypocitraturia and to urine alkalinity. The chronic acidosis and low 
bicarbonate result in the leaching of bone, leading to rickets or osteomalacia in 
severe or untreated cases (42). 
dRTA can be inherited in an autosomal dominant or an 
autosomal recessive manner. Patients with dominant (type 1a) dRTA suffer 
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from growth impairment, rickets and erythrocytosis (1) while patients with 
recessive dRTA develop progressive and irreversible bilateral sensorineural 
hearing loss (dRTA type 1b) (16).  
Type 1b dRTA is caused by mutations in the ATP6V1B1 (B1) 
and ATP6V0A4 (a4) subunits of the vacuolar H+-ATPase or in the AE1 Cl-
/HCO3- exchanger (Karet 2002). Furthermore, hypoaldosteronism or inhibition 
of mineralocorticoid receptor results in renal tubular acidosis associated with 
hyperkaliemia (type IV RTA) (38, 67) with the clinical picture similar to the 
dRTA. 
 
 
5.1.  Mutations in the B1 H+-ATPase subunit (type 1b dRTA) 
 
ATP6V1B1, the gene encoding the B1-subunit of H+-ATPase, 
resides on chromosome 2 and has made it an excellent candidate gene for 
dRTA because of its kidney specificity. Upon previous screening for mutations 
in patients with dRTA, fifteen different mutations have been revealed. 
Interestingly, almost all of the affected individuals had bilateral sensorineural 
hearing loss (43). Expression of ATP6V1B1 was also demonstrated in the 
human and mouse cochlea at the apical surface of interdental cells and in 
endolymphatic sac epithelium, a major site of acid secretion into endolymph 
(43). This acid secretion is possibly mediated by H+-ATPase containing the B1 
subunit. ATP6V1B1 expression has also been observed in the male genital 
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tract, another site with a particular acidification requirement for sperm 
maturation (39). 
 
 
5.2. Mutations in the a4 H+-ATPase subunit (type 1c dRTA) 
 
ATP6V0A4, the gene encoding the a4 H+-ATPase subunit 
resides on chromosome 7 (68). It was demonstrated in yeast that this 116 kDa 
subunit is important for assembly and the function of H+-ATPase (44). Apart 
from the presence or absence of hearing loss, there do not appear to be major 
phenotypic differences between patients with ATP6V1B1 and ATP6V0A4 
mutations. Interestingly, long-term follow-up of the patients with ATP6V0A4 
mutations who showed at the time of diagnosis normal hearing revealed that 
they develop mild to moderate hearing loss during the second to forth decade 
of life (72).  
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6. MOUSE MODELS USED IN THIS STUDY 
 
6.1. B1 H+-ATPase subunit deficient mice 
 
The Atp6v1b1-/- mouse was generated in order to elucidate the 
contribution of B1 subunit to distal urinary acidification. The Atp6v1b1 gene 
was disrupted by homologous recombination (30, 32). In contrast to human 
dRTA patients harbouring the ATP6V1B1 mutation, Atp6v1b1 –/– mice appear 
healthy and grow normally. Atp6v1b1 –/– mice fed a standard diet produce 
significantly more alkaline urine than that of wild-type littermates, without 
developing systemic acidosis. However, after oral acid challenge with NH4Cl, 
Atp6v1b1 –/– mice become acidotic, while maintaining an inappropriately 
alkaline urine, which makes them a useful model of recessive human dRTA.  
Clearance studies in anesthetized mice infused with furosemide suggest that 
the urinary acidification defect resulting from the loss of a functional B1 subunit 
may localize to the distal nephron. Increased sodium delivery from the thick 
ascending limb, sufficient to induce a significant urinary acidification in wild-
type mice, was not associated with urinary acidification in Atp6v1b1 –/– mice 
(47). Study of Atp6v1b1-/- mice of both sexes show that they are fertile (30, 
32) and have preserved hearing and no abnormalities in inner ear (22).  
 
 
6.2.  Mice with specific inactivation of αENaC subunit in 
collecting duct  
 
  The epithelial sodium channel (ENaC) is composed of three 
subunits termed α,β and γ (17). It is expressed in the aldosterone sensitive 
distal nephron (ASDN) which comprises the late distal convoluted tubule 
(DCT), CNT and CD. The role of ENaC is to mediate electrogenic sodium 
reabsorption which provides the electrochemical gradient for potassium 
secretion by ROMK channel. Inhibition of ENaC, e.g. by amiloride, leads to 
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natriuresis, hyperkaliemia and metabolic acidosis.   
Mice with complete innactivation of the α,β or γ subunit genes 
die within 2-4 days after birth as a consequence of lung fluid-clearence failure 
(40) and acute pseudohypoaldosteronism with severe hyperkaliemia and 
metabolic acidosis (7, 52). Therefore, to study sodium reabsorption along the 
ASDN, the Scnn1aloxloxCre mouse with the specific inactivation of the αENaC 
subunit in the collecting duct but not in the connecting tubule was generated 
(41, 65). This subunit plays an essential role in trafficking of the channel to the 
membrane (10).  
In our studies Scnn1aloxloxCre mice were used to investigate the 
functional interaction between sodium reabsorption and vacuolar H+-ATPase 
mediated distal urinary acidification. 
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7. AIM OF THE WORK 
 
The CNT and CD are the final regions of the nephron involved in 
the control of acid-base excretion. The fulfilment of this role is enabled by the 
epithelium which is composed of IC specialized in acid-base transport. In 
addition to intercalated cells, CNT and CD contain also principal cells which 
are involved in potassium secretion via the ROMK channel and in sodium 
reabsorption via ENaC. Sodium reabsorption creates a negative transtubular 
membrane voltage which in turn favours proton secretion by vacuolar H+-
ATPase expressed in the neighbouring type A IC. Thus, factors such as 
furosemide, which increase sodium delivery to the distal part of the nephron, 
such as furosemide, lead to enhanced sodium reabsorption by this nephron 
segment and subsequently also to enhanced proton secretion.     
The B1 H+-ATPase subunit has been shown to play a crucial role 
in disposing of acid equivalents in humans (43). The generation of mice 
deficient for the B1 subunit has made it possible to investigate the contribution 
of this subunit to the normal H+-ATPase function in type A and B IC. 
Furthermore it also provided a suitable model for studying functional 
interaction between sodium reabsorption and urinary acidification in the 
connecting tubule and collecting duct. 
The aim of this study was to investigate: 
1. Functional interaction between sodium reabsorption 
via ENaC and proton secretion via H+-ATPAse in the 
collecting duct using B1 H+-ATPase subunit and  
αENaC subunit deficient mice 
2. The contribution of B1 H+-ATPase subunit to the 
function of type B intercalated cells during alkalosis. 
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see commentary on page 1674
The connecting tubule is the main site of the
furosemide-induced urinary acidification by
the vacuolar Hþ -ATPase
J Kovacikova1, C Winter1, D Loffing-Cueni2, J Loffing2,3, KE Finberg4, RP Lifton4, E Hummler2, B Rossier2
and CA Wagner1
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of Pharmacology and Toxicology, University of Lausanne, Lausanne, Switzerland; 3Department of Medicine – Anatomy, University
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Final urinary acidification is achieved by electrogenic
vacuolar Hþ -ATPases expressed in acid-secretory
intercalated cells (ICs) in the connecting tubule (CNT) and the
cortical (CCD) and initial medullary collecting duct (MCD),
respectively. Electrogenic Naþ reabsorption via epithelial
Naþ channels (ENaCs) in the apical membrane of the
segment-specific CNT and collecting duct cells may promote
Hþ -ATPases-mediated proton secretion by creating a more
lumen-negative voltage. The exact localization where this
supposed functional interaction takes place is unknown. We
used several mouse models performing renal clearance
experiments and assessed the furosemide-induced urinary
acidification. Increasing Naþ delivery to the CNT and CCD by
blocking Naþ reabsorption in the thick ascending limb with
furosemide enhanced urinary acidification and net acid
excretion. This effect of furosemide was abolished with
amiloride or benzamil blocking ENaC action. In mice deficient
for the IC-specific B1 subunit of the vacuolar Hþ -ATPase,
furosemide led to only a small urinary acidification. In
contrast, in mice with a kidney-specific inactivation of the
alpha subunit of ENaC in the CCD and MCD, but not in the
CNT, furosemide alone and in combination with
hydrochlorothiazide induced normal urinary acidification.
These results suggest that the B1 vacuolar Hþ -ATPase
subunit is necessary for the furosemide-induced acute
urinary acidification. Loss of ENaC channels in the CCD and
MCD does not affect this acidification. Thus, functional
expression of ENaC channels in the CNT is sufficient for
furosemide-stimulated urinary acidification and identifies the
CNT as a major segment in electrogenic urinary acidification.
Kidney International (2006) 70, 1706–1716. doi:10.1038/sj.ki.5001851;
published online 20 September 2006
KEYWORDS: Hþ -ATPase; epithelial Naþ -channel; connecting tubule;
furosemide; distal renal tubular acidosis (dRTA); mouse
The kidneys play a central role in maintaining acid–base
homeostasis by reabsorbing bicarbonate and excreting acid
equivalents generated by metabolism. Final urinary acidifica-
tion takes place in the connecting tubule (CNT) and along
the different segments of the collecting duct (CD) namely the
cortical (CCD), outer medullary, and initial inner medullary
collecting duct (MCD). These parts of the nephron are
composed of segment-specific cells reabsorbing Naþ and
secreting Kþ and of intercalated cells (ICs) involved in
acid–base transport. Many studies have described functionally
and morphologically at least two types of ICs: type A and
type B.1–3 Type A ICs secrete protons via an apically expressed
vacuolar Hþ -ATPase.4 This proton secretion is functionally
coupled to the basolateral anion exchanger AE1 releasing
bicarbonate into blood. Type B ICs reverse this process,
thereby secreting bicarbonate into urine and absorbing
protons.1,5 The role of a third subtype, non-A/non-B ICs, is
not fully clarified yet.
Proton secretion through vacuolar Hþ -ATPases in the
CNT and CCD is electrogenic and is thought to be indirectly
coupled to Naþ reabsorption.4,6 Naþ reabsorption through
the amiloride-sensitive epithelial Naþ channel (ENaC)
expressed in neighboring segment-specific cells creates a
more lumen-negative potential which has been hypothetized
to enhance Hþ secretion by Hþ -ATPases.7–10 In the MCD,
ENaC expression is much lower than in the CNT and CCD,11
the lumen potential is more positive and Hþ secretion is
independent from Naþ absorption.12
The ENaC consists of three subunits termed a, b, g.13,14
Loss-of-function mutations in either the human a, b, or g
subunits of ENaC cause pseudohypoaldosteronism type 1
characterized by severe neonatal salt wasting, hyperkalemia,
and metabolic acidosis.15 The a subunit plays an essential role
in the trafficking of the channel to the cell surface as well as
forming part of the pore.13 Apart from the kidney, ENaC is
also expressed in distal colon and in upper and lower airways
where it also mediates Naþ reabsorption.14 Mice with
complete inactivation of aENaC develop acute postnatal
respiratory distress and die within 40 h of birth from failure
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to clear their lungs from liquid.16 Recently, a novel mouse
model has been generated with specific inactivation of
aENaC in the entire CD but not in CNT,17 providing a tool
for studying sodium balance as well as disturbances of proton
secretion secondary to defective Naþ absorption.
The vacuolar Hþ -ATPase is composed of at least 13
subunits of which several cell- and tissue-specific isoforms
exist.4,18,19 The B subunit forms part of the peripheral
domain V1 and two isoforms of this subunit, B1 and B2, have
been identified. Whereas the B2 isoform (ATP6V1B2) is
almost ubiquitously expressed and appears to serve in most
cells a house-keeping function, the B1 isoform (ATP6V1B1)
has a more limited tissue distribution: specialized cells of the
epididymis,20,21 the vas deferens,21 the ciliary body of the
eye,22 the inner ear,23 and all subtypes of ICs of the
kidney.20,24 Mutations in the gene encoding the B1 subunit
result in distal renal tubular acidosis (dRTA) in man
characterized by the inability of the distal nephron to
appropriately acidify the urine.23 A mouse model deficient
for the Atp6v1b1 gene has recently been generated with
impaired urinary acidification.25 Vacuolar Hþ -ATPase activ-
ity is almost completely absent from the CCD. Interestingly,
enhanced luminal appearance of the B2 subunit has been
noted in B1-deficient ICs, suggesting that the B2 isoform
could compensate for the loss of B1.25 Nevertheless,
Atp6v1b1-deficient mice develop a more severe metabolic
acidosis with inappropriately alkaline urine when challenged
with an oral acid-load (NH4Cl) characteristic of dRTA.
Different subtypes of dRTA have been proposed and
classified based on clinical tests.26,27 These tests include oral
NH4Cl- or parenteral Na2SO4-loading and application of
furosemide, which all lead to an acute urinary acidification in
healthy subjects but not in patients with specific subtypes of
dRTA. Furosemide inhibits the luminal Naþ /Kþ /2Cl
cotransporter in the thick ascending limb, thereby increasing
the delivered fraction of Naþ to the subsequent nephron
segments and stimulating Naþ reabsorption through ENaC.
Patients lacking an appropriate urinary acidification after
furosemide application have been classified as suffering from
the ‘voltage-defective’ form of dRTA.9
In order to test for and localize the possible functional
interaction between Naþ reabsorption and Hþ secretion in
the different parts of the distal nephron, we performed
clearance studies in mice treated acutely with furosemide,
hydrochlorothiazide, and amiloride, and measured urinary
acidification and net acid excretion (NAE).
RESULTS
Colocalization of vacuolar Hþ -ATPase and ENaC in
neighboring cells in the collecting system
Immunostaining of mouse kidney with antibodies against
calbindin D28k, B1 subunit of the vacuolar Hþ -ATPase, and
the b subunit of the ENaC revealed that the B1 subunit of the
Hþ -ATPase is exclusively expressed in CNTs and CDs which
were identified on account of their characteristic localization
in the cortical labyrinth and the medullary rays, respectively,
and by their strong labelling with antibodies against the beta
subunit of the epithelial sodium channel (ENaC) and the
calcium-binding protein calbindin D28k (Figure 1). Higher
magnification showed that the B1 subunit is only expressed
in a subtype of epithelial cells lining CNT and CD that do not
express bENaC or calbindinD28k. This staining pattern is
consistent with an exclusive localization of the B1 subunit in
ICs28,29 which are intermingled between the ENaC (and
calbindin) positive CNT and CD (principal) cells.
The effect of furosemide and amiloride on urinary
acidification
In a first group of control animals, the effect of acute
furosemide and subsequent amiloride application on urinary
Figure 1 | Localization of vacuolar Hþ -ATPases and the ENaC
along the CNT and CCD in mouse kidney. (a–d) Consecutive mouse
kidney sections (a/b and c/d) were stained against the B1 subunit
of the vacuolar Hþ -ATPase, the b subunit of the ENaC, and the
calbindinD28k protein. Original magnification  400. (e–g) Higher
magnification of a CCD. ICs positive for the B1 subunit are marked
with *, arrows indicate segment-specific cells stained for bENaC and
calbindinD28k. Original magnification  650.
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acidification was tested. As shown in Figure 2a, the initial
urinary pH was similar in all groups before the application of
furosemide. A bolus of furosemide (2 mg/g of body weight
(BW)) after 60 min lowered the urinary pH with being
significantly more acidic after 90 min (furosemide: pH
6.1670.08 versus control: pH 6.4970.07), after 120 min
(furosemide: pH 5.7270.10 versus control: pH 6.3970.08),
and 150 min (furosemide: 5.6370.084 versus control: pH
6.1670.05). The furosemide-induced urinary acidification
was completely abolished by the subsequent administration
of amiloride or benzamil, inhibitors of ENaC activity: pH
6.0970.09 in the furosemideþ amiloride group versus
5.7270.10 in furosemide-alone group after 120 min as well
as after 150 min: pH 6.1970.12 for furosemideþ amiloride
versus pH 5.6370.08 for furosemide alone. The urine
production and excretion remained stable in the control
group during the entire experiment, whereas it increased in
furosemide-treated animals from 1.970.3 ml/g after 60 min
to 5.270.8 ml/g after 90 min. A similar effect was observed in
mice treated subsequently with amiloride, resulting in an
increase in urine output from 3.070.6 ml/g BW after 60 min
to 6.570.7 ml/g BW after 90 min. (Figure 2b). The analysis of
urinary electrolyte excretion revealed that the fractional
excretion (FE in %) of sodium and chloride increased in mice
treated with furosemide plus amiloride (Figure 2d and e)
with a maximum after 120 min (FE of sodium 1.6770.31%
for furosemideþ amiloride versus 0.2570.08% in control
and FE of chloride 2.2970.38% in furosemideþ amiloride
versus 0.7070.24% in control). As summarized in Table 1
and Figure 3, furosemide treatment resulted in a slightly
decreased blood potassium concentration (4.870.3 mmol/l
in furosemide versus 5.770.2 mmol/l in control) and
augmented blood bicarbonate concentration (21.070.7 with
furosemide versus 19.771.0 mmol/l under control).
Thus, treatment of mice with furosemide led to the
expected increase in urinary output with an increase in
fractional sodium and potassium excretion accompanied by a
strong urinary acidification as described previously for rats
and humans.9 The stimulation of urinary acidification was
abolished by the ENaC inhibitors amiloride and benzamil
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Figure 2 | Effect of furosemide and amiloride on urinary pH and electrolyte excretion. (a) Application of furosemide (2 mg/g BW)
(n¼ 17) caused acidification of urinary pH compared to untreated wild-type mice (Atp6v1b1 þ /þ , n¼ 13). The effect of furosemide on
urine pH was reversed in mice treated subsequently with amiloride (5 mg/g BW) (n¼ 14) or benzamil (2 mg/g BW) (n¼ 6). (b) Urine production
and excretion remained stable in the control group during the experiment, whereas it increased in furosemide- and amiloride-treated
animals. (c) The FE (%) of potassium increased in furosemide-treated animals and was reversed by the addition of amiloride. (d, e) The
FE % of sodium and chloride showed an increase of both electrolytes in the furosemide- and amiloride-treated animals. *Po0.05 and
**Po0.001 versus control, #Po0.05 between furosemide treatment and furosemideþbenzamil/furosemideþ amiloride.
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consistent with a role of ENaC in the furosemide-induced
urinary acidification. A similar effect of amiloride and the
structurally unrelated ENaC blocker triamterene on the
furosemide-induced urinary acidification has also been
reported in rats.30
The furosemide-induced urinary acidification is reduced in
mice deficient for the IC-specific vacuolar Hþ -ATPase B1
subunit (ATP6V1B1)
To demonstrate that the furosemide-induced urinary acid-
ification depended on the activity of vacuolar Hþ -ATPases
localized in ICs, we used a mouse model deficient for the
IC-specific B1 subunit (Atp6v1b1 /). Atp6v1b1 /
furosemide-treated mice exhibited a markedly higher basal
urine pH than the Atp6v1b1 þ /þ furosemide-treated mice
(pH 7.1970.16 versus 6.4470.10) and only a mild urinary
acidification upon furosemide administration could be
observed: pH 6.8670.15 versus 5.7270.10 after 120 min
(Figure 4a). The residual urinary acidification observed in the
B1-deficient mice may be owing to a partial compensation by
the B2 isoform which is more luminally localized in ICs of
Atp6v1b1 / mice.25 To assess the effect of the treatments
on NAE, we measured total NH3/NH4
þ and total phosphate
excretion in urine and estimated NAE from these data as the
urine samples were too small to measure titratable acidity.
Both total NH3/NH4
þ and total phosphate excretion
increased in response to furosemide as described previously
in rats.30 Application of furosemide increased NAE from
2.970.3 mmol/l/mg/dl creatinine in control animals to
6.270.6 mmol/l/mg/dl creatinine (Figure 4b). In mice given
amiloride, NAE showed a tendency to be lower (P¼ 0.08). In
contrast, in benzamil-treated mice and in the B1-deficient
mice, NAE was significantly lower (benzamil: 3.770.6 mmol/
l/mg/dl creatinine, B1 KO: 4.470.4 mmol/l/mg/dl creati-
nine).
Atp6v1b1 / furosemide-treated mice also had a
strikingly higher urine output than the Atp6v1b1 þ /þ
furosemide-treated mice after 60 min before the furosemide
administration: 3.270.83 ml/g BW versus 1.970.34 ml/g BW
(Figure 4c). Furosemide administration led to a more
profound diuresis in Atp6v1b1 / mice: 8.971.0 ml/g BW
versus 5.270.7 ml/g BW after 90 min (Figure 4c). In addition,
Atp6v1b1 / mice had a significantly lower basal FE of
potassium than Atp6v1b1 þ /þ mice (1.8970.24 versus
6.0970.60%) (Figure 4d), basal FE of sodium (0.0670.01
versus 0.1370.01%) (Figure 4e), and basal FE of chloride
(0.0470.01 versus 0.1470.01%) (Figure 4f) pointing to a
defect in urine concentration. Furosemide administration
further revealed a significant difference in the FE of pota-
ssium, whereas the FE of sodium and chloride did not differ
between Atp6v1b1 / and Atp6v1b1 þ /þ mice (Figure 4e
and f). As summarized in Table 1 and Figure 5, analysis
of blood electrolytes revealed differences in potassium and
bicarbonate levels.
The CD-specific loss of aENaC expression in Scnn1aloxloxCre
mice does not affect the furosemide-induced urinary
acidification and diuretic response
Scnn1aloxloxCre mice lack the alpha subunit of the ENaC in the
CCD and MCD but not in the connecting segment.17 We
used these mice to test for the furosemide-stimulated urinary
acidification. Basal urine output, urine pH, and electrolyte
content were not significantly different between control mice
(Scnn1aloxlox) and mice with the specific ablation of aENaC
expression (Scnn1aloxloxCre) (compare Tables 1 and 2).
Furosemide administration caused urinary acidification in
both genotypes to a similar extent: Scnn1aloxlox and
Scnn1aloxloxCre mice: pH 6.0070.10 versus 5.8970.09 after
120 min (Figure 6a). Also, estimated NAE at the time point
150 min was similar in both groups of mice (Figure 6b;
Scnn1aloxlox 5.470.9 mmol/l/mg/dl creatinine versus
Scnn1aloxloxCre 4.270.6 mmol/l/mg/dl creatinine, P¼ 0.31).
No difference between Scnn1aloxlox and Scnn1aloxloxCre mice in
urine output could be detected (7.971.9 ml/g BW versus
8.271.1 ml/g BW after 90 min.) (Figure 6c). Furosemide also
failed to unmask a possible difference between Scnn1aloxlox
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and Scnn1aloxloxCre mice in the FE of sodium: 1.8770.42%
versus 2.1370.54% after 120 min (Figure 6e and Table 2).
However, blood electrolyte analysis revealed a significantly
lower blood bicarbonate concentration (23.570.7 mmol/l in
Scnn1aloxlox versus 21.370.7 mmol/l in Scnn1aloxloxCre (Table 2
and Figure 7b). Thus, after application of furosemide, no
significant difference was found in the diuretic response,
urinary acidification, and electrolyte excretion suggesting
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Figure 4 | Effect of furosemide on urine pH and electrolyte excretion in mice deficient for the B1 vacuolar Hþ -ATPase subunit
(Atp6v1b1 /). (a) Atp6v1b1 / received furosemide (2 mg/g BW) (n¼ 9) and urine pH acidified only mildly. **Po0.001 versus control.
(b) Estimated NAE at the time point 30 min and 150 min. NAE increased after furosemide application and the rise in NAE was significantly
reduced after application of benzamil and in the Atp6v1b1-deficient mice (*Po0.05 significant difference between furosemide-treated
animals and other groups). (c) Furosemide administration led to a more profound diuresis in Atp6v1b1 / in comparison to Atp6v1b1
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that preserved expression of aENaC in the CNT is sufficient
to maintain the furosemide-induced urinary acidification.
In order to inhibit a possible compensatory increase in
Naþ absorption in the distal tubule via the thiazide-sensitive
Naþ /Cl cotransporter, furosemide was applied together
with hydrochlorothiazide. Figure 8a shows that the urinary
pH of Scnn1aloxloxCre mice did not differ significantly from the
urine pH of Scnn1aloxlox mice before furosemide and
hydrochlorothiazide (furoþHCT) administration. After
administration of furosemide together with hydrochlorothia-
zide (furoþHCT), Scnn1aloxloxCre mice decreased their urine
pH to the same extent as the Scnn1aloxlox mice: pH 5.7770.12
versus pH 5.6670.10 after 120 min. Urine output, fractional
electrolyte excretion and systemic electrolyte, and blood gas
status were not distinguishable between both mouse lines
(Figures 8 and 9 and Table 2).
DISCUSSION
In the present study, we investigated the functional interaction
between renal Naþ reabsorption through ENaC and Hþ
secretion by vacuolar Hþ -ATPases in the connecting segment
and CCD. Both ENaC and vacuolar Hþ -ATPases containing
the B1 subunit isoform are expressed together in the same
nephron segments, namely CNT and CCD in neighboring
cells. Hþ secretion by vacuolar Hþ -ATPases is electrogenic
and thought to be indirectly coupled to Naþ reabsorption.31
According to this hypothesis, Naþ reabsorption through
ENaC creates a more lumen-negative transtubular voltage
which in turn would enhance Hþ secretion by vacuolar Hþ -
ATPases. Thus, the furosemide-induced increase in Naþ
delivery to the CNT and CCD and the subsequent reabsorp-
tion of this delivered fraction through ENaC may result in
urinary acidification mediated by vacuolar Hþ -ATPases.
Table 1 | Summary of blood pH, gas, and electrolytes of wild-type mice left untreated (control) and wild-type
and Atp6V1b1-deficient mice treated with furosemide and amiloride at the end of the experimental period
Atp6v1b1 +/+
control
Atp6v1b1 +/+
furosemide
Atp6v1b1 +/+
furosemide
amiloride
Atp6v1b1 /
furosemide
pH 7.2270.02 7.2470.02 7.2470.02 7.2570.04
pCO2 (mmHg) 50.673.9 50.872.0 47.772.1 53.877.4
HCO3
 (mmol/l) 19.771.0 21.070.7 19.870.4 21.871.6*
K+ (mmol/l) 5.770.2 4.870.3** 5.570.2 4.370.1**
Na+ (mmol/l) 145.570.8 147.770.9 145.470.5 147.671.4
Cl (mmol/l) 121.871.5 120.970.8 121.170.8 119.672.4
Serum creatinine (mg/dl) 0.1470.02 0.1170.01 0.1370.02 0.1270.01
Weight (g) 27.571.5 29.671.1 25.471.1 24.671.0
CrCl/BW 30 min (ml/min/g) 18.374.2 33.476.1 15.674.9 28.576.0
CrCl/BW 90 min (ml/min/g) 18.774.7 44.678.5* 19.073.4 26.675.6
CrCl/BW 120 min (ml/min/g) 13.873.9 33.274.6** 22.177.0 20.379.2
NH3/NH4
+ (mM)/creatinine (mg/dl), 30 min 1.0470.05 0.9470.08 1.4770.52 1.1870.15
NH3/NH4
+ (mM)/creatinine (mg/dl), 150 min 1.4070.0.18 2.6070.08 2.0470.08 2.5670.26
NAE (mM/creatinine (mg/dl), 30 min 1.2171.11 1.0370.07 1.6370.64 1.2970.20
NAE (mM/creatinine (mg/dl), 150 min 2.9170.28 6.1670.59 5.0270.33 4.4070.44*
BW, body weight; CrCl, creatinine clearance; NAE, net acid excretion.
*Marks significant differences Po0.05, **Po0.001.
Table 2 | Summary of blood pH, gas, and electrolytes of Scnn1aloxlox and Scnn1aloxloxCre mice deficient for the alpha ENaC
subunit treated with furosemide and hydrochlorothiazide
Scnn1aloxlox
furosemide
Scnn1aloxloxCre
furosemide
Scnn1aloxlox
furosemide HCT
Scnn1aloxloxCre
furosemide HCT
pH 7.2870.02 7.2870.03 7.3370.03 7.2570.03
PCO2 (mmHg) 51.472.2 47.373.1 43.974.9 55.472.1*
HCO3
 (mmol/l) 23.570.7 21.370.7* 21.970.9 23.371.3
K+ (mmol/l) 4.470.2 4.470.3 4.570.2 4.970.2
Na+ (mmol/l) 147.870.9 147.870.7 147.670.8 148.070.5
Cl (mmol/l) 119.971.8 120.271.3 114.271.5 114.671.6
Serum creatinine (mg/dl) 0.1570.02 0.1170.01 0.1470.03 0.1370.02
Weight (g) 25.471.9 24.971.2 33.671.7 29.971.9
CrCl/BW 30 min (ml/min/g) 14.473.4 21.773.3 24.1576.3 29.074.4
CrCl/BW 90 min (ml/min/g) 21.573.7 20.872.7 21.673.0 22.474.1
CrCl/BW 120 min (ml/min/g) 10.572.0 13.972.2 12.871.7 13.472.4
NH3/NH4
+ (mM)/creatinine (mg/dl), 30 min 1.2570.30 1.4770.73
NH3/NH4
+ (mM)/creatinine (mg/dl), 150 min 2.2470.36 1.8270.24
NAE (mM/creatinine (mg/dl), 30 min 1.4670.32 1.9370.70
NAE (mM/creatinine (mg/dl), 150 min 5.4170.90 4.2570.60
BW, body weight; CrCl, creatinine clearance; NAE, net acid excretion.
*Marks significant differences Po0.05, **Po0.001.
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Several types of defects in distal renal tubular acidification
have been classified based on provocative tests using infusions
containing sulfate, bicarbonate, or phosphate, oral NH4Cl
loading or furosemide application and the respective response
in urinary pH, net acid, and electrolyte excretion as well as the
ability to sustain a blood–urine PCO2 gradient.
32 At least three
types of dRTA have been distinguished, a ‘secretory type’ with
a defect supposed in the proton-secretory proton pumps, a
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Figure 6 | Effect of furosemide on urine pH and electrolyte excretion in Scnn1aloxlox and Scnn1aloxloxCre mice. (a) The effect of furosemide
on urinary acidification in Scnn1aloxlox (n¼ 10) and Scnn1aloxloxCre (n¼ 12) mice. Furosemide administration did not show any difference in urine
pH between Scnn1aloxlox and Scnn1aloxloxCre mice. (b) No difference in the furosemide-induced increase in the estimated rate of NAE was
observed between Scnn1aloxlox and Scnn1aloxloxCre treated with furosemide. (c) Urine volume/BW in Scnn1aloxlox (n¼ 11) and Scnn1aloxloxCre
(n¼ 10) mice. No difference between Scnn1aloxlox and Scnn1aloxloxCre mice in urine output was reported. (d–f) FE of potassium, sodium, and
chloride in Scnn1aloxlox (n¼ 6) and Scnn1aloxloxCre (n¼ 7) mice. Furosemide-induced increase of FE of potassium, sodium, and chloride did not
differ between Scnn1aloxlox and Scnn1aloxloxCre mice.
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Figure 7 | Effect of furosemide on blood pH and electrolytes in Scnn1aloxlox and Scnn1aloxloxCre mice. Scnn1aloxloxCre mice had a
significantly lower bicarbonate concentration. Other parameters were not different. *Po0.05 versus Scnn1aloxlox.
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‘back-leak type’ where Hþ or HCO3
 may leak back, and a
‘voltage-defective type’ where the inability to produce an acid
urine may result from the failure to produce a favorable
lumen-negative potential facilitating proton secretion.9,26,33
Consistent with these functional classifications, application of
amiloride to patients and experimental animals reduces
urinary proton secretion.9,32,34 LiCl has been used as another
tool to induce the voltage-dependent defect; however, several
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Figure 8 | (a) Effect of furosemide (2 lg/g BW) and hydrochlorothiazide (HCT, 0.05 lg/g BW) on urinary acidification in Scnn1aloxlox
(n¼ 6) and Scnn1aloxloxCre (n¼ 6) mice. Urine pH of Scnn1aloxloxCre mice did not differ significantly from the urine pH of Scnn1aloxlox mice
neither before nor after furosemideþHCT administration. (b–e) Urine output and FE of potassium, sodium, and chloride in furosemide- and
hydrochlorothiazide-treated Scnn1aloxlox (n¼ 5) and Scnn1aloxloxCre (n¼ 7) mice. No difference between Scnn1aloxlox and Scnn1aloxloxCre mice in
urine output, FE of potassium, sodium, and chloride was reported.
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Figure 9 | Blood pH and electrolytes in furosemide- and hydrochlorothiazide-treated Scnn1aloxlox (n¼ 5) and Scnn1aloxloxCre (n¼ 7)
mice. No significant difference between Scnn1aloxloxand Scnn1aloxloxCre mice in blood pH and electrolytes could be observed.
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studies have indicated that the defects induced by LiCl and
amiloride are different.35 The defect induced by administration
of LiCl can be restored by Na2SO4 infusion
32 and is associated
with altered expression levels of Hþ /Kþ -ATPases and Hþ -
ATPases.36
In our experiments, furosemide induced a strong urinary
acidification. This acidification apparently depends on the
activity of vacuolar Hþ -ATPases containing the B1 isoform
as no or only a mild acidification could be observed in
Atp6v1b1 deficient mice. Thus, vacuolar Hþ -ATPases are the
main mediator of the furosemide-induced urinary acidifica-
tion. The result also suggests that Hþ /Kþ -ATPases, the other
potential acid-secretory pumps, do not play an important
role as an acid-secretory mechanism under these experi-
mental conditions. However, we observed a lower urinary
potassium excretion in the B1-deficient mice. The mechan-
ism is presently unknown. A stimulation of Hþ /Kþ -
ATPases, potentially induced by a higher urinary flow rate,
could contribute to this effect.
The effect of furosemide was blunted by amiloride
inhibiting ENaC-dependent Naþ absorption as evident from
the increased fractional Naþ excretion and decreased
fractional Kþ -excretion. In a separate group of animals,
the consequence of the genetic ablation of ENaC channel
function was tested in Scnn1aloxloxCre mice. These animals lack
the alpha subunit of ENaC which is essential for ENaC
function and results in no detectable ENaC channel function
and loss of luminal localization of beta and gamma subunits
in the CCD and outer medullary CD.17 In the CNT, however,
ENaC function and localization has remained normal.17 In
the control and aENaC-deficient mice, furosemide induced
normal urinary acidification with a similar increase in
fractional Naþ , Cl, and Kþ excretion. In order to rule
out a compensatory increase in Naþ absorption by the
thiazide-sensitive Naþ /Cl cotransporter, we also tested for
the combined effect of furosemide and hydrochlorothiazide
which caused a stronger urinary acidification and diuretic
response to the same extent in both groups of animals. Thus,
the furosemide-induced urinary acidification involves the
activity of an amiloride- and benzamil-sensitive mechanism,
most likely ENaC. In view of the normal capacity of
Scnn1aloxloxCr mice to reabsorb Naþ and to respond to
furosemide and hydrochlorothiazide, it appears that the
residual ENaC function in the CNT may be sufficient for the
furosemide-induced urinary acidification. However, it cannot
be completely ruled out that amiloride acts also on a mech-
anism distinct from ENaC and that this mechanism is still
operative in the Scnn1aloxloxCre mice. Based on mathematical
modelling of transport processes involved in acid secretion
and electrolyte transport along the CD, it has been recently
proposed that the generation of a more lumen-negative
potential by the action of ENaC could hardly account for
changes in vacuolar Hþ -ATPase activity.7 Weinstein7 argued
that the change in transtubular voltage is minor compared to
the ability of the pump to be active even against a larger
voltage gradient, and proposed that amiloride interacts also
with other mechanisms. These calculations were made for the
CCD and may not fully apply for the CNT which was
identified here as the main target of furosemide. However,
our results do not completely rule out that some of the
urinary acidification induced by furosemide took place in the
CCD and that amiloride acted on a mechanism distinct from
ENaC. This mechanism, however, remains to be identified
and local opposing pH gradients must also be taken into
consideration. In addition, Hropot et al.30 reported that the
structurally unrelated triamterene has a similar inhibitory
effect on the furosemide-induced urinary acidification
strongly suggesting that ENaC is the common target.
This identifies the CNT as the major segment mediating
furosemide-induced urinary acidification. Similar conclu-
sions have been reached with respect to the Naþ -absorbing
capacity of the CNT versus CCD.17 Further experiments
establishing a complete genetic ablation of aENaC expression
along the entire CNT and CD will be helpful to prove this
hypothesis.
In summary, the furosemide-induced urinary acidification
requires vacuolar Hþ -ATPases containing the B1 subunit, is
inhibited by amiloride, and is not altered in a mouse model
with preserved ENaC function in the CNT but loss of ENaC
function in the CCD and outer medullary collecting duct.
The results point to a hitherto unrecognized major role of the
CNT in electrogenic Hþ -secretion and the urinary acidifica-
tion induced by furosemide.
MATERIALS AND METHODS
Animals
Experiments were performed on Atp6v1b1 þ /þ and Atp6v1b1 /
mice25) and Scnn1aloxloxCre and Scnn1aloxlox mice.17 They were
maintained on a standard diet and had a free access to drinking
water. All experiments were performed according to Swiss Animal
Welfare laws and approved by the Local Veterinary Authority.
The generation, breeding, and genotyping of Atp6v1b1/,
Scnn1aloxlox, and Scnn1aloxloxCre has been described previously.17,25
Blood and urinary parameters
Mice were anesthetized intraperitoneally (ketamine 1 ml/g BW and
xylazine 1 ml/g BW), placed on a heated table maintained at 371C
and a catheter was placed into the urinary bladder. Urine was
collected every 30 min during the whole period of 3.5 h for the
measurement of urine volume, pH, sodium, chloride, potassium,
and creatinine concentrations. To prevent dehydration, mice were
constantly supplemented with 125 mM NaCl and 25 mM NaHCO3
(pH 7.4) according to their urinary output. At the end of the
experiment, heparinized mixed venous blood was collected for the
measurement of pH, blood gases, sodium, potassium, chloride, and
creatinine concentrations. After an initial recovery phase and
collection of a baseline value at 30 min, at 60 min Atp6v1b1 þ /þ ,
Atp6v1b1 /, Scnn1aloxlox, and Scnn1aloxloxCre mice were
administered furosemide 2 mg/g BW subcutaneously; some of the
Scnn1aloxlox and Scnn1aloxloxCre mice were also given hydrochloro-
thiazide 0.05 mg/g BW together with furosemide. Two subgroups of
Atp6v1b1 þ /þ mice received additionally amiloride 5 mg/g BW
subcutaneously or benzamil 2 mg/g BW subcutaneously after 90 and
120 min of the experiment. All drugs were finally dissolved in
1714 Kidney International (2006) 70, 1706–1716
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125 mM NaClþ 25 mM NaHCO3. Control mice received only 125 mM
NaClþ 25 mM NaHCO3.
Urinary pH was immediately measured; urine and blood
electrolytes and other blood parameters (pCO2, pO2) were
determined using a blood gas analyzer (ABL 505, Radiometer,
Copenhagen, Denmark). Urinary creatinine was measured by the
Jaffe method. Serum creatinine was determined by an enzymatic
reaction (F DAOS method, Wako Creatinine F L-Type kit, Wako
Chemicals GmbH, Germany). Total urinary NH3/NH4
þ was
measured using the Berthelot protocol,37 total urinary phosphate
using a commercial kit (Sigma, Buchs, Switzerland). NAE was
estimated from the concentration of total NH3/NH4
þ , total
phosphate as the major titratable acid, and urine pH using the
Henderson–Hasselbalch equation and assuming blood pH 7.4.
Immunohistochemistry
Fixation of mouse kidneys and tissue processing for immuno-
histochemistry was performed as described previously.28 Consecu-
tive cryosections (4–5 mm thick) of the fixed kidneys were placed on
chrom-alum gelatine-coated slides, preincubated with 10% normal
goat serum in phosphate-buffered saline, and afterwards incubated
overnight at 41C with mouse-anti-chicken calbindin D28k anti-
bodies (Swant Bellinzona, Switzerland, dilution 1/20 000 in
phosphate-buffered saline-1% bovine serum albumin) that was
applied together with either rabbit-anti-rat bENaC antisera17
(dilution 1/1000 in phosphate-buffered saline-1% bovine serum
albumin) or rabbit-anti-rabbit B1 subunit of Hþ -ATPase20 (dilu-
tion 1/1000 in phosphate-buffered saline-1% bovine serum
albumin). Binding sites of the primary antibodies were revealed
with fluorescein isothiocynate-coupled goat-anti-mouse immuno-
globulin G and Cy3-coupled goat-anti-rabbit immunoglobulin G
(both from Jackson Immuno Research Laboratories, West Grove,
PA, USA).
Statistical analysis
All data were tested for statistical analysis using paired and unpaired
Student’s t-tests and analysis of variance, and only data with Po0.05
were considered statistically significant. A minimum of 6–8 animals
was used for each measurement and treatment.
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ABSTRACT 
 
Non-type A intercalated cells (IC) in the connecting tubule (CNT) and cortical collecting duct 
(CCD) express the luminal Cl-/HCO3- exchanger pendrin and apical and/or basolateral 
vacuolar H+-ATPases containing the B1 subunit isoform. The main function of non-type A-
ICs  is the excretion of bicarbonate during metabolic alkalosis. Non-type A-IC may also 
participate in chloride reabsorption. Mutations in the B1 subunit (ATP6V1B1) in man cause 
distal renal tubular acidosis due to its importance in acid secretion by type A-ICs. However, 
the function of the B1 isoform in non-type A-ICs has remained elusive. Induction of 
metabolic alkalosis resulted in a more pronounced alkalosis in B1 deficient mice associated 
with increased blood bicarbonate, hypokalemia, and hypochloremia. Furthermore, total 
pendrin expression was reduced in B1 deficient mice whereas the relative abundance of 
pendrin expressing cells was increased. H+-ATPase activity in ICs was strongly reduced. 
Moreover, the a4 and A H+-ATPase subunits did not associate with the basolateral domain 
of B1 deficient non-A-ICs. Thus, the B1 subunit is required for the formation of complete and 
functional basolateral H+-ATPases complexes. B1 deficient mice excreted also larger 
quantities of urine which was associated with lower AQP-2 water channel abundance and a 
higher relative frequency of principal cells in the connecting tubule. Thus, the B1 H+-ATPase 
subunit is critical for normal non-type A IC function and its loss may also affect the function 
of principal cells.  
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INTRODUCTION  
 
The final urinary secretion of acid or base equivalents is fine tuned by intercalated 
cells (IC) along the connecting tubule (CNT) and collecting duct (CD) and involves the 
action of vacuolar H+-ATPases and several Cl-/HCO3- -exchangers. Many studies have 
described functionally and morphologically at least two types of IC: type A and type B (1, 15, 
25). The existence of a third type (non-A-non-B IC) has been proposed (12, 27). However, 
the functional significance of this subtype has not been clarified. A type IC secrete protons 
via an apically expressed vacuolar H+-ATPase (32). This proton secretion is functionally 
coupled to the basolateral anion exchanger AE1 releasing bicarbonate into blood. Non-type 
A-ICs (i.e. type B-IC and non-A-non-B-IC) express the anion exchanger pendrin apically and 
vacuolar H+-ATPases on the apical and/or basolateral membrane and functionally reverse 
these processes, thus, secreting bicarbonate (25, 34). Thus, non-A-IC mediate the excretion 
of an alkali-load during metabolic alkalosis (15, 25). Furthermore, recently a role of non-A-
ICs in transcellular chloride reabsorption via the apical Cl-/HCO3- -exchanger pendrin has 
been proposed (22, 28, 37, 39).  
 
The vacuolar H+-ATPase is composed of at least 13 subunits. Several studies (18, 
42) demonstrated that the B subunit plays an essential role in vacuolar H+-ATPase function. 
This subunit is a part of the peripheral catalytic V1 domain and exists in two highly 
homologous isoforms: B1 and B2 (29). The B2 subunit is considered to be ubiquitous and 
seems mainly to mediate the acidification of intracellular organelles. The B1 subunit, on the 
contrary, has been identified in a limited number of tissues, often in cells where plasma 
membrane H+-ATPase mediates proton extrusion. The B1 subunit has been detected in 
specialized cells of the epididymis  (3, 4, 7), the vas deferens, the ciliar body of the eye (41), 
in the inner ear (11)  and in all subtypes of intercalated cells of the kidney (7, 19). 
 
Mutations in the gene encoding the B1 subunit (ATP6V1B1) result in distal renal 
tubular acidosis (dRTA) in man characterized by the inability of the distal nephron to 
appropriately acidify the urine (11).  A mouse model deficient for the Atp6v1b1 gene showed 
impaired H+-secretion in the collecting duct (6, 14). These findings demonstrate the 
importance of the B1 subunit as a part of the apical H+-ATPase complex for normal type A-
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IC function. However, the function of H+-ATPases containing the B1 subunit in non-type A-
ICs has remained elusive to date.  
 
Basolateral H+-ATPases in type B IC are thought to be important for H+ absorption 
during metabolic alkalosis. Metabolic alkalosis causes hypertrophy of type B-IC with 
amplification of the basolateral plasma membrane and the insertion of proton pumps into 
this membrane (25). Thus, IC respond to metabolic alkalosis by increasing bicarbonate 
secretion presumably via the apical Cl-/HCO3- -exchanger pendrin, and enhancement of 
proton absorption across the basolateral membrane of type B IC. 
 
In non-type A-IC H+-ATPases function in series with pendrin (PDS). In the kidney, 
pendrin is expressed exclusively in the distal convoluted tubule (DCT), CNT, and CCD in the 
apical membrane of non-type A-ICs (38). However, pendrin deficient mice are not 
spontaneously alkalotic. Under conditions that increase pendrin function such as 
administration of aldosterone analogues together with NaHCO3 application or dietary NaCl 
restriction, differences between Pds -/- and Pds+/+ mice in arterial blood pH and blood 
pressure become apparent (30, 39).  
 
Here we tested for a role of H+-ATPases containing the B1 isoform in the function of 
non-type A intercalated cells and used a mouse model lacking the B1 subunit (Atp6v1b1-/-). 
During metabolic alkolosis, B1 deficient mice displayed a distinct defect of non-type A-ICs. 
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METHODS 
 
Animals 
 
Experiments were performed on Atp6v1b1 +/- and Atp6v1b1 -/- mice (6)  All 
experiments were performed according to Swiss Animal Welfare laws and approved by the 
local veterinary authority (Kantonales Veterinäramt Zürich). The generation and breeding of 
Atp6v1b1-/- deficient mice (all in the C57BL/6J background) has been described previously 
(6, 14).  
 
  
Metabolic cage studies 
 
Atp6v1b1 +/- and Atp6v1b1 -/- mice (male, 6-10 animals per group) were kept in 
metabolic cages and had free access to standard mouse chow and drinking water. After 24 
hours urine was collected, mice were injected with deoxycorticosterone acetate (DOCA) 2 
mg/ animal s.c. and switched to alkaline diet for 4 days. The alkaline diet consisted of 
standard mouse chow and addition of 0.28 M NaHCO3 plus 2 % sucrose to drinking water. 
Daily food and water intake, and body weights were measured and urine was collected 
under oil. At the end of experiment mixed arterial and venous blood was collected for the 
measurement of pH, blood gases, electrolytes, and creatinine concentrations.  
 Urinary pH was measured using a pH microelectrode, urine and blood electrolytes 
and other blood parameters (pCO2, pO2) were determined using a blood gas analyzer (ABL 
505, Radiometer, Copenhagen, Denmark). Urinary creatinine was measured by the Jaffe 
method. Creatinine in serum was determined by an enzymatic reaction (F DAOS method) 
using a commercial kit (Wako Creatinine F L-Type kit, Wako Chemicals GmbH, Germany). 
Urinary ammonium was measured by the method of Berthelot, urinary phosphate and citrate 
were determined using a commercial kit (Sigma Diagnostics, St. Louis, Mo., USA and Citric 
acid kit, Boehringer Mannheim, Germany).  
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Immunohistochemistry 
 
Atp6v1b1 +/- and Atp6v1b1 -/- mice were anesthetized with ketamine/xylazine and perfused 
through the left ventricle with PBS followed by paraformaldehyde-lysine-periodate (PLP) 
fixative (16). Kidneys were removed and fixed overnight at 4°C by immersion in PLP. 
Kidneys were washed three times with PBS, and 7-μm cryosections were cut after 
cryoprotection with 0.9 M sucrose in PBS/ 0.02% sodium azide for at least 1 h. 
Immunostaining was carried out as described (33). The following primary antibodies were 
used: rabbit anti-pendrin 1:1000, rabbit anti-a4 H+-ATPase 1:1000 (36), rabbit anti-A H+-
ATPase, rabbit anti-B1 H+-ATPase 1:500, rabbit anti-B2 H+-ATPase, goat anti AQP-2 (Santa 
Cruz Biotechnology), 1:400 and mouse anti-calbindin D28k 1:20 000 (SWANT, Bellinzona, 
Switzerland). The secondary antibodies were donkey anti-rabbit 586 and donkey anti-goat 
488 (Molecular Probes) at 1:1,000 and 1:300, respectively. All antibodies were tested and 
no staining was detected with pre-immune sera, in the presence of the immunizing peptide, 
or when the primary antibodies were omitted. 
 
 
Western blotting 
 
Animals were killed, and kidneys were rapidly harvested. Immunoblotting was performed on 
total kidney crude membrane fractions as described previously (33). The primary antibodies 
were rabbit anti-pendrin 1:5000, AQP2 1:10 000 (kindly provided by J. Loffing, University of 
Fribourg, Switzerland), and mouse monoclonal anti-actin (42 kD; Sigma, St. Louis, MO) 
1:5000. The secondary antibodies  (donkey anti-rabbit 1:10,000 IgG conjugated with 
horseradish peroxidase [Amersham Life Sciences] and sheep anti-mouse 1:5000 IgG-
conjugated with alkaline phosphatase) were detected with the enhanced 
chemiluminescence ECL kit (Amersham Pharmacia Biotech, UK) or the CDP star kit (Roche 
Diagnostics, Basel, Switzerland). 
 For each sample, the ratio of the protein of interest to actin was determined and used 
to calculate the ratio between the group of Atp6v1b1 +/- mice and Atp6v1b1 -/- mice.  
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Tubule Preparation and Intracellular pH Measurements  
Intracellular pH (pHi) was monitored in single type intercalated cells in isolated CCDs that 
were prepared as described (36). CCDs were identified and incubated with the pH-sensitive 
dye BCECF (1 µM, Molecular Probes) for 10 min and washed to remove all nondeesterified 
dye. Each experiment was calibrated with the high K+/nigericin technique as described (35, 
36). All experiments were performed in the absence of bicarbonate. The initial solution was 
a HEPES-buffered Ringer solution (125 mM NaCl/3mMKCl/1 mM CaCl2/1.2 mM 
MgSO4/2mMKH2PO4/32.2 mM Hepes, pH 7.4). Cells were acidified by using the NH4Cl (20 
mM) prepulse technique and washed into a Na+-free solution (Na+ was replaced by 
equimolar concentrations of N-methyl-D-glucamine). The rate of H+-ATPase activity was 
determined as the concanamycin-sensitive pHi alkalinization rate in the absence of Na+. 
Rates were calculated over the same range of pHi (6.40–6.80) for all cells studied. All 
chemicals were of highest purity and were purchased from Sigma (St. Louis, Mo., USA).  
 
Statistical analysis 
 
All data were tested for statistical analysis using Student’s t-tests and only data with 
P < 0.05 were considered statistically significant. 
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RESULTS 
 
The B1 isoform is part of the basolateral H+-ATPase complex in mouse kidney during 
metabolic alkalosis 
 
Immunostaining of mouse kidney with antibodies against the B1 subunit of the 
vacuolar H+-ATPase confirmed the localization at the basolateral side of intercalated cells of 
the cortical collecting duct (Fig. 1) as described previously in mouse and rat kidney (7, 19). 
Staining was absent from kidneys of Atp6v1b1-/- mice. Thus, the B1 subunit forms part of 
the basolateral H+-ATPase complex of non-type A intercalated cells in mouse kidney. 
 
 
Absence of the B1 subunit enhances susceptibility to metabolic alkalosis 
 
To test for a role of the B1 subunit in non-type A intercalated cells, we induced 
metabolic alkalosis using the aldosterone analogue desoxycorticosterone (DOCA,  2 
mg/mouse s.c.) and addition of NaHCO3 to the drinking water as described previously (30). 
 Treatment with DOCA and NaHCO3 resulted in a significantly stronger metabolic 
alkalosis in B1 deficient mice than in the control littermates. Blood pH and bicarbonate 
concentration were higher in Atp6v1b1-/- mice (Table 1, Fig. 2A). Metabolic alkalosis was 
associated with hypokalemia and hypochloremia in Atp6v1b1 -/- mice (Tab. 1, Fig. 2C, D) as 
described previously in similar states (10). However, hypokalemia and hypochloremia were 
significantly more pronounced in Atp6v1b1-/- mice.   Prior to the treatment, urine pH of 
Atp6v1b1 -/- mice was significantly more alkaline as described previously (6) (Tab 2, Fig. 
3A). Treatment with DOCA and NaHCO3 increased urine pH to a similar extent in Atp6v1b1-
/- mice to 8.57 ± 0.01 and in Atp6v1b1+/- to 8.33 ± 0.05 (Tab. 2, Fig. 3A). Consistently, urine 
HCO3- excretion increased in both groups with HCO3- levels significantly higher in Atp6v1b1-
/- (Fig. 2B). Furthermore, alkaline diet-induced elevated urinary potassium and sodium 
losses were more apparent in Atp6v1b1-/- mice (Fig. 3C, D). However, a significant 
difference in urine chloride concentration was observed only in the first day of treatment 
(Fig. 3E). Water and bicarbonate intake were similar in both groups.  
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Thus, absence of the B1 H+-ATPase subunit makes mice more susceptible to metabolic 
alkalosis suggesting an important role in the clearance from an alkali load.  
 
 
H+-ATPase localizes to apical and basolateral membranes of IC in Atp6v1b1 -/- and 
Atp6v1b1 +/- mice  
 
To establish the presence and distribution of H+-ATPase subunits in the connecting 
tubule and cortical collecting duct, the two segments participating in active bicarbonate 
secretion, we performed immunostaining against the a4 and A H+-ATPase subunits. The a4 
subunit belongs to the membrane bound V0 sector, whereas the A subunit forms part of the 
cytosolic V1 sector (32). In kidneys from alkalotic Atp6v1b1+/- mice antibodies against the 
a4 or A subunit clearly stained the basolateral membrane of a subpopulation of intercalated 
cells in the CCD (Fig. 4) as described previously for these and other H+-ATPase subunits in 
mouse, rat or rabbit kidney during alkalosis (2, 13, 26, 31). In the CCD of Atp6v1b1-/- mice, 
staining for the membrane bound a4 subunit was preserved in the basolateral membrane of 
CCD intercalated cells. In contrast, the A subunit showed mostly a diffuse and cytoplasmic 
or a clear apical staining but was almost absent from the basolateral side (Fig. 4). In the 
apical membrane of type A intercalated cells, staining for the B2 isoform has been observed 
under conditions of acidosis or in the absence of the B1 isoform suggesting a compensatory 
mechanism (6, 21). However, we failed to detect staining for the B2 subunit in the 
basolateral membrane of alkalotic Atp6v1b1+/- and Atp6v1b1-/- mice whereas a clear 
staining of the apical membrane was seen in most CCD intercalated cells (Fig. 4).  
 
 
H+-ATPase activity is attenuated in IC from alkalotic Atp6v1b1-/- mice   
To assess the H+-ATPase activity in non-type A intercalated cells we used isolated 
CCDs from alkalotic mice. Under these conditions, the majority of intercalated cells in the 
mouse CCD are non-type A intercalated cells. The initial intracellular pH (pHi) of single 
intercalated cells in superfused CCDs was 7.19 ± 0.02 in Atp6v1b1+/- and 7.27 ± 0.02 in 
Atp6v1b1-/-. Removal of Na+ from the bath led to an intracellular acidification, which was 
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further enhanced after an NH4Cl prepulse (20 mM) (Fig. 5). In the continued absence of Na+ 
the IC of Atp6v1b1+/- mice alkalinized pHi by 0.042 ± 0.003 pHi units/min.. In contrast, in the 
IC of Atp6v1b1-/- mice the alkalinization rate was only 0.023 ± 0.002 pHi units/min (p < 
0.001) (Fig. 5). Readdition of Na+ to the bath led to a rapid alkalinization to the initial pHi 
values in both groups mediated by Na+/H+ exchange (36). We used concanamycin (200 nM, 
a specific vacuolar H+-ATPase inhibitor, to separate H+-ATPase activity from H+/K+-ATPase 
activity (5). Under these conditions, the alkalinization rate declined to 0.021 ± 0.001 pHi 
units/min in Atp6v1b1-/- and to 0.023 ± 0.001 pHi units/min in Atp6v1b1+/- most likely 
representing H+/K+-ATPase activity. H+-ATPase activity was calculated by subtracting ’’ 
concanamycin’’ values from ’’control’’ values within the respective groups. H+-ATPase 
activity in IC from Atp6v1b1-/- mice was approximately 7-fold lower than in IC from 
Atp6v1b1+/- (0.003 ±0.001 vs. 0.019 ±0.002; p < 0.001) (Fig. 5).  
 
Pendrin expression is reduced in kidneys from Atp6v1b1-/- mice 
 
Pendrin in kidney is exclusively expressed in non-type A intercalated cells and its 
abundance, localization, and presence have been linked to non-type A IC functions such as 
bicarbonate secretion and chloride absorption (22, 23, 33, 39). Under control conditions 
pendrin protein expression was lower in Atp6v1b1-/- mice (0.56 ± 0.04 vs. 1.0 ± 0.11; p < 
0.01) (Fig. 6A, B). Similarly, under DOCA + NaHCO3 treatment pendrin abundance was 
reduced in B1 deficient mice (0.48 ± 0.03 vs. 1.0 ± 0.13; p < 0.01) (Fig. 6C, D).  
To test possible differences in subcellular localization of pendrin, immunostaining 
against pendrin was performed on kidney samples from Atp6v1b1-/- and Atp6v1b1+/- mice. 
Pendrin was seen in the cortex in the CNT and CCD localized in a rim in the apical 
membrane of a subpopulation of intercalated cells both in Atp6v1b1 -/- and Atp6v1b1 +/- 
mouse kidneys (Fig. 7). Thus, the abundance of pendrin is reduced but the apical 
localization is preserved in kidneys of mice deficient for the B1 H+-ATPase subunit. 
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Alkalotic Atp6v1b1 -/- mice have higher abundance of non-type A intercalated cells 
and principal cells 
 
 To further characterize the underlying cause for the reduced pendrin expression, we 
assessed the relative abundance of type A and non-type A intercalated cells and principal 
cells in the CNT and CCD. Kidneys were stained against pendrin and the principal cell 
specific proteins calbindin D28k (CNT) and AQP2 (CNT and CCD). Cells were counted as 
being pendrin positive (non-type A intercalated cells), AQP-2/calbindin positive (principal 
cells) or pendrin and AQP2/calbindin negative (type A intercalated cells).  
In the CNT of Atp6v1b1-/- mice the percentage of type A IC declined to 3.8 ± 0.5 % 
from 12.0 ± 2.3 % in Atp6v1b1+/- (p< 0.0017) without changing the percentage of non-type 
A IC significantly (30.6 ± 1.3 % in Atp6v1b1-/- vs. 33.9 ± 1.5 % in Atp6v1b1+/-, n.s.). 
However, the percentage of principal cells was significantly increased (65.7 ± 1.5 in 
Atp6v1b1-/- vs. 54.1 ± 2.8 in Atp6v1b1+/-) (Table 3). In contrast, in the CCD of Atp6v1b1-/- 
mice a significantly larger population of non-type A IC was observed (30.8 ± 2.0 % vs. 22.3 
± 1.3 %), whereas the abundance of type A IC was significantly decreased (4.5 ± 0.7 % vs. 
19.4 ± 2.2 %). The percentage of CCD principal cells in Atp6v1b1-/- mice was slightly 
increased without reaching significance (64.7 ± 1.9 % vs. 58.4 ± 2.5 %) (Table 3). Thus, 
absence of the B1 subunit in animals treated with DOCA/HCO3- causes remodelling of the 
connecting tubule and cortical collecting duct with an increase in the relative abundance of 
non-type a IC in the CCD and more principal cells in the CNT. 
 
Dysregulation of AQP2 in Atp6v1b1-/- mice  
 Metabolic cage studies showed a tendency to higher urinary output in Atp6v1b1-/- 
under control conditions and after treatment with DOCA/NaHCO3- (Table 2). This tendency 
was associated with significantly lower urinary osmolarity under control conditions 
(Atpv1b1+/-: 2256.8 ± 188.0 mOsm versus Atp6v1b1-/-:1708.8 ± 84.6 mOsm.). In addition, 
we had recently observed that B1 deficient mice had a significantly higher urinary flow upon 
application of the diuretic furosemide during clearance experiments (14). Thus, absence of 
the B1 subunit may also alter renal water handling and urinary concentration. To investigate 
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this possibility we tested AQP2 abundance in control and DOCA/NaHCO3 treated kidneys. 
Under control conditions AQP2 expression in Atp6v1b1-/- mice was not significantly different 
(glycosylated band: 1.54 ± 0.19 versus 1.0 ± 0.22 in Atp6v1b1+/- and non-glycosylated 
band: 1.31 ± 0.12 versus 1.0 ± 0.23 in Atp6v1b1+/-) (Fig. 8A-C). DOCA/NaHCO3 treatment 
resulted in downregulation of AQP2 in Atp6v1b1-/- mice (glycosylated band: 0.36 ± 0.03 
versus 1.0 ± 0.12 in Atp6v1b1+/-; p< 0.01 and non-glycosylated band: 0.35 ± 0.05 versus 
1.0 ± 0.07 in Atp6v1b1+/-; p< 0.001) (Fig. 8D-F).    
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DISCUSSION 
Vacuolar H+-ATPases are expressed in all types of intercalated cells and to date no 
specific subunit isoforms have been identified that can be linked to the function of only one 
subtype of intercalated cells (32). The B1 subunit isoform is almost exclusively expressed in 
the intercalated cells with only low abundance also in the thick ascending limb (17, 19). Its 
importance in type A intercalated cell function has been highlighted by the fact that 
mutations in the ATP6V1B1 gene in patients leads to distal renal tubular acidosis (11). Also, 
genetic ablation of the murine homologue, Atp6v1b1, impairs maximal urinary acidification 
(6, 14). However, the function of the B1 isoform in non-type A intercalated cells has 
remained elusive. Therefore, we investigated the role of the B1 H+-ATPase subunit in non-
type A IC function using a mouse model lacking the B1 subunit.  
We used a treatment that has been shown to provoke metabolic alkalosis in mice 
(23). Our findings clearly demonstrate that the B1 subunit is critical for non-type A 
intercalated cell function both on the systemic level of the whole animal as well as on the 
cellular level. Atp6v1b1-/- mice developed a more pronounced alkalosis with hypochloremia 
and hypokalemia. This alkalosis is most likely due to the failure of non-type A intercalated 
cells to excrete appropriate amounts of bicarbonate into urine. Even though urinary 
bicarbonate/ creatinine was elevated in B1 deficient mice, this may be rather due to 
exceeding the threshold for bicarbonate reabsorption in the proximal tubule which is in the 
range of 25-28 mM (9). B1 deficient mice showed blood bicarbonate levels well above this 
threshold. However, the abundance of pendrin representing most likely the apical and rate-
limiting bicarbonate extruding pathway in non-type A intercalated cells was strongly reduced 
in kidneys of B1 KO mice. Absence of pendrin has been previously shown to impair 
bicarbonate excretion in the cortical collecting duct from pendrin deficient mice (23). The 
reduction in pendrin expression reflects decreased pendrin abundance per cell as detailed 
cell counts demonstrated that the number of pendrin expressing cells is markedly increased 
which may represent a compensatory mechanism to counter-act alkalosis. Similarly, Wall 
and colleagues have demonstrated that in the kidney of the pendrin deficient mouse, 
several transport proteins of non-type A-IC are down-regulated (39). Taken together, it 
appears that loss of proteins critically involved either in proton or bicarbonate extrusion 
 
 
 
 
 
13
affects the expression of the other components of this functional transport unit. The loss of 
this transport unit apparently triggers remodelling of the cellular composition of the 
connecting tubule and cortical collecting duct, as shown here. The underlying mechanism of 
this compensatory remodelling remains to be identified.  
Regulation of H+-ATPase activity may involve assembly of domains or subunits and 
trafficking to the membrane (20, 32). Immunohistochemistry demonstrated that absence of 
the B1 subunit from the basolateral side of non-type A-IC could not be compensated by the 
B2 subunit isoform. The B2 isoform was only found in the apical domain of intercalated cells 
in the B1 deficient mouse but was never seen on the basolateral side. The a4 subunit, 
belonging to membrane bound V0 domain was still found in the basolateral side of non-type 
A-IC indicating that trafficking of the pump or at least of parts of it is not generally impaired 
in the absence of the B1 isoform. In control animals, the A subunit, part of the cytosolic V1 
domain and directly neighboring the B (B1 or B2) subunit, was frequently found in the 
basolateral domain of non-type A-IC. In contrast, in the absence of the B1 subunit, the A 
subunit was seen either in the apical domain or was rather diffusely distributed in the 
cytosol. Similarly, Yang et al. demonstrated recently that in the assembly of H+-ATPase 
complexes in vitro was disturbed in the presence of mutated B1 subunits (43). Thus, the B1 
subunit may be required for the normal assembly of the V1 and V0 domains of basolateral 
H+-ATPase complexes both in vitro and in vivo. This notion is also supported by the fact that 
H+-ATPase activity of intercalated cells in the CCD from B1 deficient mice is strongly 
reduced. As we were not able to distinguish between type A and  non-type A IC and 
between apical and basolateral H+-ATPase activity in our preparation, the residual activity 
may reflect either type A intercalated cells or apical H+-ATPase complexes. However, it 
should be noted that pendrin staining and cell counts indicated that a large fraction of 
intercalated cells in the CCD were non-type A-IC.  
Apart from the alkalosis, Atp6v1b1v1 -/- mice showed a tendency to have increased 
blood osmolarity and significantly decreased urinary osmolarity pointing to a possible urinary 
concentrating defect.  Total AQP2 expression was decreased under these conditions 
whereas the relative abundance of AQP2 positive cells was increased suggesting an 
adaptive process possibly limiting excessive water loss.  The underlying mechanism of 
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AQP2 dysregulation is not clear at this state, however, expression of the B1 subunit in 
principal cells (24) and bafilomycin-sensitive AQP2 recycling have been described (8). Since 
the presence of other H+-ATPase subunits was not confirmed in these recycling vesicles 
(24) and the vesicles fail to acidify their lumen (40) the B1 subunit may perform functions in 
principal cells unrelated to classic H+-ATPase activity.  
Thus, the B1 subunit is critical for normal formation and function of basolateral H+-
ATPase complexes in non-type A intercalated cells. To our knowledge, this is the first in vivo 
evidence for the importance of this subunit to H+-ATPase assembly. In addition, the function 
of the B1 subunit may also extend to the regulation of AQP2 water channels either directly 
or indirectly. 
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FIGURE LEGENDS 
 
Table 1 
Blood parameters in Atp6v1b1+/- and Atp6v1b1 -/- mice treated by DOCA/NaHCO3 for 
4 days. N = 6 mice/ group, values are means ± SE. **p< 0.01 and ***p < 0.001 Atp6v1b1+/- 
versus Atp6v1b1-/- mice.  
 
Table 2 
Urine parameters from control and DOCA/NaHCO3 treated Atp6v1b1+/- and Atp6v1b1-
/- mice. Animals were kept in metabolic cages and 24 hour urine collections performed 
before (control) and after 4 days of DOCA/NaHCO3 treatment. Values are as means ± SE; V 
volume; BW body weight; CreaCl creatinine clearance; crea creatinine; FE fractional 
excretion. *p < 0.05, **p< 0.01 and ***p < 0.001 DOCA/NaHCO3 Atp6v1b1+/- respectively 
Atp6v1b1-/- versus control Atp6v1b1+/- respectively Atp6v1b1-/- mice. #p < 0.05, ##p < 0.01 
and ###p < 0.001 control Atp6v1b1-/- versus control Atp6v1b1+/- mice. &p < 0.05, &&p< 0.01 
and &&&p < 0.001 DOCA/NaHCO3 Atp6v1b1-/- versus DOCA/NaHCO3 Atp6v1b1+/- mice. 
 
Table 3 
Relative abundance of different cell types in the CNT and CCD of DOCA/NaHCO3 
treated Atp6v1b1+/- and Atp6v1b1-/- mice. Values are means ± SE. **p < 0.01 and ***p < 
0.001 Atp6v1b1+/- versus Atp6v1b1-/- mice. 
 
Figure 1 
Staining for the B1 subunit in kidneys from Atp6v1b1+/- and Atp6v1b1-/- mice. (A,B) 
The B1 subunit (red) localized in kidneys of Atp6v1b1+/- to the apical and basolateral 
(marked with *) membranes of intercalated cells in the CCD. Principal cells are stained with 
AQP2/ calbindin D28k (green). (C, D) No staining for B1 was detected in kidneys from 
Atp6v1b1-/- mice. Original magnification: A: 630 x, B-D: 400 x. 
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Figure 2 
Blood parameters after 4 days DOCA/NaHCO3 treatment. (A) Atp6v1b1-/- mice had a 
more alkaline blood pH, (B) increased HCO3- level, (C) hyperchloremia and (D) 
hypokaliemia. **p < 0.01 and ***p < 0.001 Atp6v1b1+/- versus Atp6v1b1-/- mice. 
 
Figure 3 
Urine pH and electrolyte levels before and after 4 days DOCA/NaHCO3 treatment. (A) 
Prior to the treatment urine pH was significantly higher in Atp6v1b1-/- mice and increased in 
both groups during the treatment. (B-E) Urinary electrolyte excretion. *p < 0.05, **p < 0.01 
and ***p < 0.001 Atp6v1b1+/- versus Atp6v1b1-/- mice.  
 
Figure 4 
Localization of H+-ATPase subunits in CCD non-type A intercalated cells. (A, B) The 
B2 subunit (red) was found mostly in the cytosol of CCD intercalated cells in kidneys of 
Atp6v1b1+/- animals (A) whereas a more pronounced apical B2 staining was observed in 
the CCD of B1 deficient mice (B). (C, D) The a4 subunit (red) was located to the apical and 
basolateral (arrow) membrane of CCD intercalated cells both in Atp6v1b1+/- and Atp6V1b1-
/- animals. (E, F) The A subunit (red) was seen in the apical and basolateral (arrow) 
membrane of CCD intercalated cells in control animals, but could not be found in the 
basolateral membrane in the absence of the B1 subunit (G,H). Principal cells were stained 
with antibodies against AQP2 and calbindin D28k (green). Original magnification 400 – 600 
x. 
 
Figure 5 
H+-ATPase activity in single CCD intercalated cells of Atp6v1b1+/- and Atp6v1b1-/- 
mice. 
(A-D) Original tracings of intracellular pH measurements in single intercalated cells in CCDs 
isolated from the kidney of alkalotic Atp6v1b1+/- and Atp6v1b1-/- mice in the absence and 
presence of the specific H+-ATPase inhibitor concanamycin (200 nM). (E) Summary of pHi 
recovery rate measurements and calculation of H+-ATPase activity (difference control – 
concanamycin). ***p < 0.001 Atp6v1b1+/- versus Atp6v1b1-/-. 
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Figure 6 
Pendrin abundance in control and DOCA/NaHCO3 treated mice. Pendrin expression 
was reduced both in control (A,B) and DOCA/NaHCO3 treated (C,D) Atp6v1b1-/- mice. **p 
< 0.01 Atp6v1b1+/- versus Atp6v1b1-/-. 
 
Figure 7 
Pendrin localization is preserved in Atp6v1b1 -/- mice. Immunostaining against pendrin 
(red) did not show any difference between alkalotic Atp6v1b1+/- and Atp6v1b1-/- mice. 
Principal cells were stained with AQP2 (green). Original magnification 400 x. 
 
Figure 8 
AQP2 abundance is reduced in alkalotic Atp6v1b1-/- mice.  A-C) Under control 
conditions Atp6v1b -/- mice have slightly increased AQP2 abundance without reaching 
significance. (D-F) In Atp6v1b1-/- mice DOCA/NaHCO3 treatment resulted in decreased 
AQP2 abundance. Gly glycosylated AQP2, non-gly non-glycosylated AQP2. **p < 0.01 and 
***p < 0.001 Atp6v1b1+/- versus Atp6v1b1-/-. 
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Table 1  
 
  
 
Atp6v1b1 +/-       Atp6v1b1 -/-   
 
 pH 
pCO2 [mmHg] 
pO2 [mmHg] 
HCO3- [mmol/l] 
K+ [mmol/l] 
Na+ [mmol/l] 
Cl- [mmol/l] 
Crea [mmol/l] 
Osmolarity [mOsm] 
7.29 ± 0.02 
48.2 ± 1.9 
42.6 ± 6.8 
22.7 ± 0.6 
3.6 ± 0.1 
145.6 ± 1.0 
109.5 ± 1.0 
0.11 ± 0.01 
324.0 ± 8.5 
7.40 ± 0.02 ** 
51.3 ± 3.1 
47.4 ± 10.9 
31.2 ± 1.9 *** 
2.5 ± 0.1 ***  
147.2 ± 0.8 
101.2 ± 2.2 ** 
0.09 ± 0.11 
341.6 ± 8.9  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 
 
 
Atp6v1b1+/- Atp6v1b1-/-  
control DOCA/ NaHCO3  control DOCA/ NaHCO3  
pH 
V [ml/g BW/24hours] 
CreaCl [μl/gBW/24hours] 
Crea [mg/dl] 
HCO3-/ Crea [mmol/l/mg/dl] 
K+/ Crea [mmol/l/mg/dl] 
Na+/Crea [mmol/l/mg/dl] 
Cl-/ Crea [mmol/l/mg/dl] 
NH4+/ Crea [mmol/l/mg/dl] 
H2PO4-/Crea [mmol/l/mg/dl] 
Citrate/ Crea  
FE (HCO3-) [%] 
FE (K+) [%] 
FE (Na+) [%] 
FE (Cl-) [%] 
Osmolarity [mOsm] 
∆ weight [%] 
6.29 ± 0.10 
0.07 ± 0.02 
 
51.6 ± 2.12 
0.0 ± 0.0 
2.3 ± 0.3 
2.3 ± 0.3 
5.6 ± 0.7 
0.89 ± 0.05 
0.004 ± 0.001 
1.9 ± 0.6 
 
 
 
 
2256.8 ±188 
 
8.33 ± 0.05 *** 
0.17 ± 0.02 * 
58.9 ± 8.3 
33.8 ± 3.0 
4.5 ± 0.7 *** 
2.0 ± 0.1 
10.2 ± 0.8 *** 
3.7 ± 0.4 * 
0.17 ± 0.04 *** 
0.003 ± 0.001 
13.8 ± 0.9 *** 
1.9 ± 0.3 
5.3 ± 0.8 
0.68 ± 0.01 
0.32 ±0.06 
1387.2 ± 133.9 ** 
+ 3.6 ± 1.1 
6.81 ± 0.05 ##
0.09 ± 0.01 
 
44.2 ± 1.9 #
0.2 ± 0.0 ###
2.7 ± 0.1 
2.2 ± 0.1 
4.9 ± 0.4 
1.17 ± 0.05 ##
0.003 ± 0.001 
0.2 ± 0.1 
 
 
 
 
1708.8 ± 84.6 #
8.57 ± 0.01 *** & 
0.21 ± 0.04 * 
59.4 ± 11.4 
23.1 ± 1.1 *** &
10.0 ± 0.6 *** &&&
2.2 ± 0.2 
14.2 ± 0.4 *** &&
3.2 ± 0.5 * 
0.20 ± 0.05 *** 
0.005 ± 0.001 * &
11.2 ± 1.8 ** 
2.5 ± 0.3 
6.9 ± 0.6 
0.77 ± 0.03 
0.23 ± 0.04 
1209.6 ± 76.4 ** 
-0.3 ± 2.2 
 
 
 
 
 
 
 
 
 
Table 3  
 
Results from cell counting 
 
CNT CCD  
Atp6v1b1 +/- Atp6v1b1 -/- Atp6v1b1 +/- Atp6v1b1 -/- 
Pendrin negative 
AQP2/calbindin negative (%) 
 
Pendrin positive (%) 
 
AQP2/ calbindin positive (%) 
 
12.0 ± 2.3 
 
33.9 ± 1.5 
 
54.1 ± 2.8 
 
3.7 ± 0.5 ** 
 
30.6 ± 1.3 
 
65.8 ± 1.5 ***
 
19.4 ± 2.2 
 
22.3 ± 1.4 
 
58.4 ± 2.5  
 
4.5 ± 0.7 *** 
 
30.8 ± 2.0*** 
 
64.7 ± 1.9 
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9. SUMMARY OF THE RESULTS 
 
9.1. Functional interaction between sodium reabsorption and 
urinary acidification by the vacuolar H+-ATPase in the 
CNT and CD 
 
Final urinary acidification is achieved by the action of vacuolar 
H+-ATPases expressed in the IC of the CNT and CD. It has been 
hypothesised that this acidification is enhanced by sodium reabsorption 
through ENaC which is expressed on the apical membranes of neighbouring 
principal cells, thereby creating a more lumen-negative voltage. 
Renal clearence experiments in a mouse model deficient for the 
B1 H+-ATPase subunit and a mouse model with the specific inactivation of 
αENaC in the CD but not in the CNT enabled us to study the exact localization 
of this interaction. Furosemide was chosen as a tool for triggering urinary 
acidification by increasing sodium delivery to the CNT and CD. This effect of 
furosemide was abolished with amiloride and benzamil which block ENaC. In 
mice deficient for B1 H+-ATPase subunit furosemide led to only a small urinary 
acidification. On the contrary, in mice with the specific inactivation of αENaC in 
the CD, furosemide alone and in combination with hydrochlorothiazide induced 
normal urinary acidification.  
Taken together these findings suggest that the B1 vacuolar H+-
ATPase subunit is necessary for acute urinary acidification. Loss of αENaC in 
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the CD does not impair final urinary acidification. Hence, the expression of 
functional ENaC channels in the CNT is sufficient to cause furosemide-
stimulated urinary acidification and identifies the CNT as a major segment in 
electrogenic urinary acidification.   
 
          
9.2. The role of the B1 H+-ATPase subunit in type B IC 
function 
 
The role of the B1 H+-ATPase subunit in the type A IC has been 
highlighted in humans and mice (30, 43). However B1 containing proton 
pumps are also present on the basolateral membrane of the type B IC where 
their function is to reabsorb protons. This process serves, together with 
bicarbonate secretion through the apical Cl-/HCO3- exchanger pendrin, to 
dispose alkali equivalents. Thus, type B IC are crucial during metabolic 
alkalosis. 
To date little was known about the role of the B1 H+-ATPase 
subunit in the type B IC. To study this aspect, we induced metabolic alkalosis 
using deoxycorticosterone acetate (DOCA) and NaHCO3 in B1 deficient mice. 
Following this treatment, B1 knock out mice developed systemic alkalosis 
accompanied by increased blood bicarbonate, hypokaliemia and 
hypochloremia. Furthermore, B1 deficient mice showed decreased total 
pendrin expression whereas the relative abundance of pendrin expressing 
cells was increased. H+-ATPase activity in B-IC was strongly reduced, 
30
 
demonstrating that B1 containing H+-ATPases are essential for normal type B 
intercalated cell function. Furthermore, B1 deficient mice excreted larger 
quantities of urine which was associated with a lower AQP-2 water channel 
abundance and a higher relative frequency of principal cells in the connecting 
tubule. 
Thus, the B1 H+-ATPase subunit is essential for normal B-type 
IC function and its loss may also affect the function of the principal cells. The 
role of the B1 subunit function in bicarbonate secretion and water reabsorption 
have been previously not recognized and may also affect renal function in 
patients with ATP6V1B1 mutations. 
 
 
9.3. The role of the B1 H+-ATPase subunit in the type A and B 
IC: an integrative view 
 
The vacuolar H+-ATPase is a multisubunit protein with the B 
subunit forming a part of the cytosolic V1 domain. This subunit exists in two 
isoforms - B1 and B2, with only the B1 subunit and not the B2 subunit 
possessing a PDZ binding motif. Whereas the B2 subunit is expressed in 
virtually all tissues, the B1 subunit expression is restricted to a limited number 
of tissues such as kidney, testis and inner ear.  
The kidney specific B1 subunit is present in the vacuolar H+-
ATPase in the intercalated cells of the CNT and CD. Vacuolar H+-ATPases are 
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expressed on the apical membrane of the acid-secretory type A IC and on the 
basolateral membrane of the base-secretory type B IC.  
The role of the B1 subunit in the type A IC has been recognized 
in humans and mice. Human patients harbouring mutations in the B1 subunit 
suffer from dRTA, in which the distal nephron is unable to acidify the urine 
appropriately resulting in systemic acidosis. Mice deficient for the B1 subunit 
are not spontaneously acidotic despite the excretion of alkaline urine. However 
following NH4Cl load or furosemide administration they acidify their urine to a 
lesser extent than wild type animals. Furthermore, activity of the H+-ATPases 
lacking the B1 subunit is significantly reduced in the type A IC (unpublished 
observations), but is still preserved to a certain extent suggesting a possible 
compensation by the ubiquitous B2 subunit. This explanation is supported by 
the findings of other group (60). 
In the type B IC loss of the B1 subunit is associated with a 
decreased pendrin expression. Pendrin is an apical Cl-/HCO3- exchanger 
which functions in series with the basolateral proton pump. Furthermore, the 
activity of the H+-ATPase lacking the B1 subunit is negligible in this type of 
cells. This finding provides evidence that the B2 subunit may not be able to 
compensate for the loss of the B1 subunit in type B IC. In addition, the B2 
subunit was not observed in the basolateral membrane of the IC. 
Taken together the data suggest that although the B2 subunit 
may be able to partially compensate for the absence of the B1 subunit in type 
A IC H+-ATPases, no such compensation by B2 occurs for type B IC B1-
deficient H+-ATPases.  This lack of compensation by the B2 subunit in 
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basolateral localized H+-ATPase may be due to the lack of a PDZ binding 
domain restricting expression of B2 to apical membranes such as in type A IC.   
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WORK 
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10.1. Impact of dietary protein intake on acid-base status in a 
mouse    model for distal renal tubular acidosis 
 
Kovacikova J, Wagner CA 
 
Manuscript in preparation 
 
Abstract: 
Distal renal tubular acidosis (dRTA) is caused by impaired excretion of acid in 
the renal collecting duct and affects systemic mineral and electrolyte balance. 
A protein rich Western diet constitutes a physiological acid-load which requires 
increased urinary acidification. Patients with mutations in the intercalated cell 
specific B1 subunit of the vacuolar H+-ATPase suffer from dRTA. Recently we 
described a mouse model lacking the B1 subunit with impaired urinary 
acidification. WT and B1 KO mice were fed over 10 weeks with a normal (NP, 
20%) or high protein (HP, 50%) diet. Surprisingly B1 KO grew more on the HP 
and increased blood pH and bicarbonate levels. Urinary pH was more alkaline 
in the B1 KO. WT animals responded with an increased urinary excretion of 
Na, Cl, Pi, whereas B1 KO had low excretion rates. Thus, the physiological 
acid load with a HP diet does not lead to dRTA in mice lacking the B1 subunit 
and possibly triggers a complex compensatory mechanism.  
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10.2. Thyroid hormone modulates expression of acid-base 
transporters in rat kidney 
 
Mohebbi N, Kovacikova J, Nowik M, Wagner CA 
 
Am J Physiol Renal Physiol; manuscript submitted 
 
Abstract: 
Hypothyroidism in man is associated with incomplete distal renal tubular 
acidosis, presenting as the inability to respond appropriately to an acid 
challenge by excreting less acid. Here, we induced hypothyroidism in rats with 
methimozole (HYPO) and substituted one group with L-thyroxine (EU). After 4 
weeks, acid base status was similar in both groups. However, after 24 hours 
acid loading with NH4Cl HYPO rats displayed a more pronounced metabolic 
acidosis. The expression of the Na+/H+ exchanger NHE3, the na+/phosphate 
cotransporter Napi IIa and the B2 subunit of the vacuolar H+-ATPase was 
reduced in the brush border membrane of the proximal tubule of the HYPO 
group paralleled by a lower abundance of Na+/HCO3- cotransporter NBCe1 
and a higher expression of the acid-secretory type A intercallated cell specific 
Cl-/HCO3- exchanger AE1. In contrast to control conditions, the expression of 
NBCe1 was increased in the HYPO group during metabolic acidosis. In 
addition, net acid excretion was similar in both groups. The relative number of 
type A intercalated cells was increased in the connecting tubule and cortical 
collecting duct of the HYPO group during acidosis. Thus, thyroid hormones 
modulate the renal response to an acid challenge and alter the expression of 
several key acid-base transporters. Mild hypothyroidism is associated only 
with a very mild defect in renal acid handling which appears to be mainly 
located in the proximal tubule and is compensated by the distal nephron.      
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10.3. Distal renal tubular acidosis in mice lacking aldosterone 
synthase 
 
Kovacikova J, Makhanova N, Kim HS, Smithies O, Wagner CA 
 
Manuscript in preparation 
 
Abstract:  
The ability of the kidney to acidify urine is modulated by aldosterone. Acquired 
or inborn defects associated with aldosterone insufficiency result in a form of 
hyperkalemic distal renal tubular acidosis (type IV dRTA). However, previous 
animal models have been based on adrenalectomy which also affects a 
number of other hormones that may be involved in acid-base homeostasis. 
Here we examined a mouse model lacking aldosterone synthase (AS KO) 
catalyzing the final step in aldosterone synthesis. AS KO have lower blood pH, 
lower bicarbonate and chloride level as well as mild hyperkaliemia. These 
changes are accompanied by a higher urine output, a more alkaline urine, 
increased water and food inatake and diarrhoe. In the kidney, absence of 
aldosterone led to increased levels of AE1 mRNA and protein and increased 
AQP2 protein abundance. The expression of NHE3 both on mRNA as well as 
on protein level was not altered. Real time PCR did not reveal any changes in 
the abundance of SNAT3, PEPCK, pendrin, a4 and B1 H+-ATPase subunits in 
kidney. Despite metabolic acidosis the kidney did not adapt adequately by 
increasing net acid excretion enough suggesting a renal defect in 
ammoniagenesis and final urinary acidification. In addition, mild diarrhoe may 
lead to intestinal electrolyte and bicarbonate loss and could thereby contribute 
to the observed disturbances. Our results suggest that mice lacking 
aldosterone synthase have symptoms of dRTA type IV and therefore may 
serve as a model to further investigate aldosterone related regulation of renal 
(and extra-renal) acid-base transport. 
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10.4. Angiotensin II stimulates vacuolar H+-ATPase activity in 
renal acid-secretory intercalated cells. The B1 vacuolar 
H+-ATPase subunit (ATP6V1B1) is required for the 
stimulation 
 
Rothenberger F, Velic A, Stehberger PA, Kovacikova J, Wagner CA   
 
J Am Soc Nephrol; manuscript submitted 
 
Abstract: 
Final urinary acidification is mediated by the action of vacuolar H+-ATPases 
expressed in acid-secretory type A intercalated cells (A-IC) in the collecting 
duct. Angiotensin II (A II) has profound effects on renal acid-base transport in 
the proximal tubule, distal tubule, and collecting duct. Here we investigated its 
effects on vacuolar H+-ATPase activity in A-IC in freshly isolated mouse outer 
medullary collecting ducts. A II (10 nM) stimulated concanamycin-sensitive 
vacuolar H+-ATPase activity in A-ICin freshly isolated mouse outer medullary 
collecting ducts via AT1 receptors which were also detected 
mmunohistochemically in A-IC. A II increased intracellular Ca2+ levels 
transiently. Chelation of intracellular Ca2+ with BAPTA and depletion of ER 
Ca2+-stores prevented the stimulatory effect on H+-ATPase activity. The 
effect of A II on H+-ATPase activity was abolished by inhibitors of small G-
proteins and phospholipase C, by blockers of Ca2+-dependent and 
independent isoforms of protein kinase C and ERK1/2 kinases. Disruption of 
the microtubular network and cleavage of cellubrevine attenuated the 
stimulation. Finally, A II failed to stimulate residual vacuolar H+-ATPase 
activity in A-IC from mice deficient for the B1 subunit of the vacuolar H+-
ATPase. Thus, A II presents a potent stimulus for vacuolar H+-ATPase activity 
in OMCD intercalated cells and requires trafficking of stimulatory proteins or 
vacuolar H+-ATPases. The B1 subunit is indispensable for the stimulation by 
A II and its importance for stimulation of vacuolar H+-ATPase activity may 
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contribute to the inappropriate urinary acidification seen in distal renal tubular 
acidosis patients with mutations in this subunit. 
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10.5. Enhanced suicidal death of erythrocytes from gene-
targeted mice lacking the Cl-/HCO3- exchanger AE1 
 
 
Akel A, Wagner CA, Kovacikova J, Kasinathan RS, Kiedaisch V, Koka S, 
Alper SL, Bernhardt I, Wieder T, Huber S, Lang F 
 
Am J Physiol Cell Physiol; manuscript submitted 
 
 
Abstract: 
Genetic defects of the anion exchanger AE1 may lead to spherocytic erythrocyte 
morphology, severe hemolytic anemia and/or cation leak. In normal erythrocytes 
osmotic shock, Cl- removal and energy depletion activate Ca2+-permeable cation 
channels with Ca2+ induced suicidal erythrocyte death, i.e. surface exposure of 
phosphatidylserine, cell shrinkage and membrane blebbing, all features typical 
for apoptosis of nucleated cells. The present experiments explored whether AE1 
deficiency favors suicidal erythrocyte death. Peripheral blood erythrocyte 
number was significantly smaller in gene-targeted mice lacking AE1 (AE1-/-) than 
in their wild type littermates (AE1+/+), despite an increased percentage of 
reticulocytes (AE1-/-: 49%, AE1+/+: 2%), an indicator of enhanced erythropoiesis. 
Annexin binding reflecting phosphatidylserine exposure was significantly larger 
in AE1-/-erythrocytes/reticulocytes (~10 %) than in AE1+/+erythrocytes (~1 %). 
Osmotic shock (addition of 400 mM sucrose), Cl- removal (replacement with 
gluconate) or energy depletion (removal of glucose) led to significantly stronger 
annexin binding in AE1-/-erythrocytes/reticulocytes than in AE1+/+erythrocytes. 
The increase of annexin binding following exposure to the Ca2+ ionophore 
ionomycin (1 µM) was, however, similar in AE1-/- and in AE1+/+erythrocytes. 
Fluo3 fluorescence revealed markedly increased cytosolic Ca2+ permeability in 
AE1-/- erythrocytes/reticulocytes. Clearance of CFSE-labelled 
erythrocytes/reticulocytes from circulating blood was more rapid in AE1-/- than in 
AE1+/+mice and accelerated by ionomycin treatment in both genotypes. In 
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conclusion, lack of AE1 is associated with enhanced Ca2+ entry and subsequent 
scrambling of cell membrane phospholipids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41
 
REFERENCES 
 
 
1. Agroyannis B, Koutsikos D, Tzanatos-Exarchou H, and Yatzidis H. 
Erythrocytosis in type I renal tubular acidosis with nephrocalcinosis. Nephrol 
Dial Transplant 7: 365-366, 1992. 
2. Al-Awqati Q. Plasticity in epithelial polarity of renal intercalated cells: 
targeting of the H(+)-ATPase and band 3. Am J Physiol 270: C1571-1580, 
1996. 
3. Al-Awqati Q, Norby LH, Mueller A, and Steinmetz PR. 
Characteristics of stimulation of H+ transport by aldosterone in turtle urinary 
bladder. J Clin Invest 58: 351-358, 1976. 
4. Allen AM, Zhuo J, and Mendelsohn FA. Localization and function of 
angiotensin AT1 receptors. Am J Hypertens 13: 31S-38S, 2000. 
5. Ardaillou R. Angiotensin II receptors. J Am Soc Nephrol 10 Suppl 11: 
S30-39, 1999. 
6. Bagnis C, Marshansky V, Breton S, and Brown D. Remodeling the 
cellular profile of collecting ducts by chronic carbonic anhydrase inhibition. Am 
J Physiol Renal Physiol 280: F437-448, 2001. 
7. Barker PM, Nguyen MS, Gatzy JT, Grubb B, Norman H, Hummler E, 
Rossier B, Boucher RC, and Koller B. Role of gammaENaC subunit in lung 
liquid clearance and electrolyte balance in newborn mice. Insights into 
perinatal adaptation and pseudohypoaldosteronism. J Clin Invest 102: 1634-
1640, 1998. 
8. Bastani B, Purcell H, Hemken P, Trigg D, and Gluck S. Expression 
and distribution of renal vacuolar proton-translocating adenosine 
triphosphatase in response to chronic acid and alkali loads in the rat. J Clin 
Invest 88: 126-136, 1991. 
9. Batlle DC. Segmental characterization of defects in collecting tubule 
acidification. Kidney Int 30: 546-554, 1986. 
10. Bonny O, Chraibi A, Loffing J, Jaeger NF, Grunder S, Horisberger 
JD, and Rossier BC. Functional expression of a pseudohypoaldosteronism 
type I mutated epithelial Na+ channel lacking the pore-forming region of its 
alpha subunit. J Clin Invest 104: 967-974, 1999. 
11. Breton S, Smith PJ, Lui B, and Brown D. Acidification of the male 
reproductive tract by a proton pumping (H+)-ATPase. Nat Med 2: 470-472, 
1996. 
 
42
 
12. Breton S, Wiederhold T, Marshansky V, Nsumu NN, Ramesh V, and 
Brown D. The B1 subunit of the H+ATPase is a PDZ-binding protein. J Biol 
Chem 275: 18219-18224, 2000. 
13. Brown D, Hirsch S, and Gluck S. An H+-ATPase in opposite plasma 
membrane domains in kidney epithelial cell subpopulations. Nature 331: 622-
624, 1988. 
14. Brown D, Hirsch S, and Gluck S. Localization of a proton-pumping 
ATPase in rat kidney. J Clin Invest 82: 2114-2126, 1988. 
15. Brown D, Lui B, Gluck S, and Sabolic I. A plasma membrane proton 
ATPase in specialized cells of rat epididymis. Am J Physiol 263: C913-C916, 
1992. 
16. Brown MT, Cunningham MJ, Ingelfinger JR, and Becker AN. 
Progressive sensorineural hearing loss in association with distal renal tubular 
acidosis. Arch Otolaryngol Head Neck Surg 119: 458-460, 1993. 
17. Canessa CM, Schild L, Buell G, Thorens B, Gautschi I, Horisberger 
JD, and Rossier BC. Amiloride-sensitive epithelial Na+ channel is made of 
three homologous subunits. Nature 367: 463-467, 1994. 
18. Chan YL and Giebisch G. Relationship between sodium and 
bicarbonate transport in the rat proximal convoluted tubule. Am J Physiol 240: 
F222-230, 1981. 
19. Chang H and Fujita T. A numerical model of acid-base transport in rat 
distal tubule. Am J Physiol Renal Physiol 281: F222-F243, 2001. 
20. Choi JY, Shah M, Lee MG, Schultheis PJ, Shull GE, Muallem S, and 
Baum M. Novel amiloride-sensitive sodium-dependent proton secretion in the 
mouse proximal convoluted tubule. J Clin Invest 105: 1141-1146, 2000. 
21. Couloigner V, Teixeira M, Hulin P, Sterkers O, Bichara M, Escoubet 
B, Planelles G, and Ferrary E. Effect of locally applied drugs on the pH of 
luminal fluid in the endolymphatic sac of guinea pig. Am J Physiol Regul Integr 
Comp Physiol 279: R1695-1700, 2000. 
22. Dou H, Finberg K, Cardell EL, Lifton R, and Choo D. Mice lacking 
the B1 subunit of H+ -ATPase have normal hearing. Hear Res 180: 76-84, 
2003. 
23. DuBose TD and Alpern RJ. Renal tubular acidosis. In: The metabolic 
and molecular bases of inherited disease (8th ed.), edited by Scriver CR, 
Beaudet AL, Sly WS and Valle D. New York: McGraw-Hill, 2001, p. 4983-
5021. 
 
43
 
24. DuBose TD, Jr. and Caflisch CR. Effect of selective aldosterone 
deficiency on acidification in nephron segments of the rat inner medulla. J Clin 
Invest 82: 1624-1632, 1988. 
25. DuBose TD, Jr., Gitomer J, and Codina J. H+,K+-ATPase. Curr Opin 
Nephrol Hypertens 8: 597-602, 1999. 
26. Emmons C and Kurtz I. Functional characterization of three 
intercalated cell subtypes in the rabbit outer cortical collecting duct. J Clin 
Invest 93: 417-423, 1994. 
27. Fejes-Toth G and Naray-Fejes-Toth A. Differentiation of renal beta-
intercalated cells to alpha-intercalated and principal cells in culture. Proc Natl 
Acad Sci U S A 89: 5487-5491, 1992. 
28. Fejes-Toth G and Naray-Fejes-Toth A. Immunohistochemical 
localization of colonic H-K-ATPase to the apical membrane of connecting 
tubule cells. Am J Physiol Renal Physiol 281: F318-325, 2001. 
29. Ferrary E and Sterkers O. Mechanisms of endolymph secretion. 
Kidney Int Suppl 65: S98-103, 1998. 
30. Finberg KE, Wagner CA, Bailey MA, Paunescu TG, Breton S, 
Brown D, Giebisch G, Geibel JP, and Lifton RP. The B1-subunit of the H(+) 
ATPase is required for maximal urinary acidification. Proc Natl Acad Sci U S A 
102: 13616-13621, 2005. 
31. Finberg KE, Wagner CA, Bailey MA, Wang T, Mentone SA, 
Kashgarian M, Giebisch G, Geibel JP, and Lifton RP. Loss of plasma 
membrane H+-ATPase activity from cortical collecting duct intercalated cells of 
H+-ATPase B1-subunit deficient mice: a mouse model of distal renal tubular 
acidosis (Abstract). J Am Soc Nephrol 13: 4, 2002. 
32. Finberg KE, Wang T, C.A. W, Geibel JP, Dou H, and Lifton RP. 
Generation and characterization of H+-ATPase B1 subunit deficient mice 
(Abstract). J Am Soc Nephrol 12: 15, 2001. 
33. Frische S, Kwon TH, Frokiaer J, Madsen KM, and Nielsen S. 
Regulated expression of pendrin in rat kidney in response to chronic NH4Cl or 
NaHCO3 loading. Am J Physiol Renal Physiol 284: F584-593, 2003. 
34. Geibel J, Giebisch G, and Boron WF. Angiotensin II stimulates both 
Na(+)-H+ exchange and Na+/HCO3- cotransport in the rabbit proximal tubule. 
Proc Natl Acad Sci U S A 87: 7917-7920, 1990. 
35. Giebisch G. Renal potassium transport: mechanisms and regulation. 
Am J Physiol 274: F817-833, 1998. 
 
44
 
36. Gruber G, Wieczorek H, Harvey WR, and Muller V. Structure-function 
relationships of A-, F- and V-ATPases. J Exp Biol 204: 2597-2605, 2001. 
37. Hamm LL and Alpern RJ. Cellular mechanisms of renal tubular 
acidification. In: The Kidney: Physiology and Pathophysiology, edited by 
Seldin DW and Giebisch G. Philadelphia: PA: Lippincott Williams & Wilkins, 
2000, p. 1935-1979. 
38. Henger A, Tutt P, Riesen WF, Hulter HN, and Krapf R. Acid-base and 
endocrine effects of aldosterone and angiotensin II inhibition in metabolic 
acidosis in human patients. J Lab Clin Med 136: 379-389, 2000. 
39. Herak-Kramberger CM, Breton S, Brown D, Kraus O, and Sabolic I. 
Distribution of the vacuolar H+ atpase along the rat and human male 
reproductive tract. Biol Reprod 64: 1699-1707, 2001. 
40. Hummler E, Barker P, Gatzy J, Beermann F, Verdumo C, Schmidt 
A, Boucher R, and Rossier BC. Early death due to defective neonatal lung 
liquid clearance in alpha-ENaC-deficient mice. Nat Genet 12: 325-328, 1996. 
41. Hummler E, Merillat AM, Rubera I, Rossier BC, and Beermann F. 
Conditional gene targeting of the Scnn1a (alphaENaC) gene locus. Genesis 
32: 169-172, 2002. 
42. Karet FE. Inherited distal renal tubular acidosis. J Am Soc Nephrol 13: 
2178-2184, 2002. 
43. Karet FE, Finberg KE, Nelson RD, Nayr A, Mocan H, Sanjad SA, 
Rodriguez-Soriano J, Santos F, Cremers CW, Di Pietro A, Hoffbrand BI, 
Winiarski J, Bakkaloglu A, Ozen S, Dusunsel R, Goodyer P, Hulton SA, 
Wu DK, Skvorak AB, Morton CC, Cunnigham MJ, Jha V, and Lifton RP. 
Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular 
acidosis with sensorineural deafness. Nat Genet 21: 84-90, 1999. 
44. Kawasaki-Nishi S, Bowers K, Nishi T, Forgac M, and Stevens TH. 
The amino-terminal domain of the vacuolar proton-translocating ATPase a 
subunit controls targeting and in vivo dissociation, and the carboxyl-terminal 
domain affects coupling of proton transport and ATP hydrolysis. J Biol Chem 
276: 47411-47420, 2001. 
45. Kawasaki-Nishi S, Nishi T, and Forgac M. Arg-735 of the 100-kDa 
subunit a of the yeast V-ATPase is essential for proton translocation. Proc Natl 
Acad Sci U S A 98: 12397-12402, 2001. 
46. Kim J, Kim YH, Cha JH, Tisher CC, and Madsen KM. Intercalated cell 
subtypes in connecting tubule and cortical collecting duct of rat and mouse. J 
Am Soc Nephrol 10: 1-12, 1999. 
 
45
 
47. Kovacikova J, Winter C, Loffing-Cueni D, Loffing J, Finberg KE, 
Lifton RP, Hummler E, Rossier B, and Wagner CA. The connecting tubule 
is the main site of the furosemide-induced urinary acidification by the vacuolar 
H+-ATPase. Kidney Int: (in press), 2006. 
48. Leng XH, Manolson MF, Liu Q, and Forgac M. Site-directed 
mutagenesis of the 100-kDa subunit (Vph1p) of the yeast vacuolar (H+)-
ATPase. J Biol Chem 271: 22487-22493, 1996. 
49. Lombes M, Farman N, Oblin ME, Baulieu EE, Bonvalet JP, Erlanger 
BF, and Gasc JM. Immunohistochemical localization of renal 
mineralocorticoid receptor by using an anti-idiotypic antibody that is an internal 
image of aldosterone. Proc Natl Acad Sci U S A 87: 1086-1088, 1990. 
50. Losel R and Wehling M. Nongenomic actions of steroid hormones. Nat 
Rev Mol Cell Biol 4: 46-56, 2003. 
51. Madsen KM, Verlander JW, Kim J, and Tisher CC. Morphological 
adaptation of the collecting duct to acid-base disturbances. Kidney Int Suppl 
33: S57-63, 1991. 
52. McDonald FJ, Yang B, Hrstka RF, Drummond HA, Tarr DE, McCray 
PB, Jr., Stokes JB, Welsh MJ, and Williamson RA. Disruption of the beta 
subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal 
death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad 
Sci U S A 96: 1727-1731, 1999. 
53. Merot J, Giebisch G, and Geibel J. Intracellular acidification induces 
Cl/HCO3 exchange activity in the basolateral membrane of beta-intercalated 
cells of the rabbit cortical collecting duct. J Membr Biol 159: 253-262, 1997. 
54. Miller RL, Zhang P, Smith M, Beaulieu V, Paunescu TG, Brown D, 
Breton S, and Nelson RD. V-ATPase B1-subunit promoter drives expression 
of EGFP in intercalated cells of kidney, clear cells of epididymis and airway 
cells of lung in transgenic mice. Am J Physiol Cell Physiol 288: C1134-1144, 
2005. 
55. Mohebbi N, Kovacikova J, Nowik M, and Wagner C. Thyroid 
hormone modulates expression of acid-base transporters in rat kidney. Am J 
Physiol Real Physiol manuscript submitted, 2007. 
56. Muller V and Gruber G. ATP synthases: structure, function and 
evolution of unique energy converters. Cell Mol Life Sci 60: 474-494, 2003. 
57. Nelson H and Nelson N. Disruption of genes encoding subunits of 
yeast vacuolar H+-ATPase causes conditional lethality. Proc Natl Acad Sci 
USA 87: 3503-3507, 1990. 
 
46
 
58. Nelson N and Harvey WR. Vacuolar and plasma membrane proton-
adenosinetriphosphatases. Physiol Rev 79: 361-385, 1999. 
59. Nelson RD, Guo XL, Masood K, Brown D, Kalkbrenner M, and 
Gluck S. Selectively amplified expression of an isoform of the vacuolar H+-
ATPase 56-kilodalton in renal intercalated cells. Proc Natl Acad Sci USA 89: 
3541-3545, 1992. 
60. Paunescu TG, Da Silva N, Marshansky V, McKee M, Breton S, and 
Brown D. Expression of the 56-kDa B2 subunit isoform of the vacuolar H+-
ATPase in proton-secreting cells of the kidney and epididymis. Am J Physiol 
Cell Physiol 287: C149-C162, 2004. 
61. Powell B, Graham LA, and Stevens TH. Molecular characterization of 
the yeast vacuolar H+-ATPase proton pore. J Biol Chem 275: 23654-23660, 
2000. 
62. Puopolo K, Kumamoto C, Adachi I, Magner R, and Forgac M. 
Differential expression of the "B" subunit of the vacuolar H(+)-ATPase in 
bovine tissues. J Biol Chem 267: 3696-3706, 1992. 
63. Rothenberger F, Velic A, Stehberger P, Kovacikova J, and Wagner 
CA. Angiotensin II stimulates vacuolar H+-ATPase activity in renal acid-
secretory intercalated cells. The B1 vacuolar H+-ATPase subunit (ATP6V1B1) 
is required for stimulation. J Am Soc Nephrol, 2007. 
64. Royaux IE, Wall SM, Karniski LP, Everett LA, Suzuki K, Knepper 
MA, and Green ED. Pendrin, encoded by the Pendred's syndrome gene, 
resides in the apical region of renal intercalated cells and mediates 
bicarbonate secretion. Proc Natl Acad Sci USA 98: 4221-4226, 2001. 
65. Rubera I, Loffing J, Palmer LG, Frindt G, Fowler-Jaeger N, Sauter 
D, Carroll T, McMahon A, Hummler E, and Rossier BC. Collecting duct-
specific gene inactivation of alphaENaC in the mouse kidney does not impair 
sodium and potassium balance. J Clin Invest 112: 554-565, 2003. 
66. Schuster VL. Function and regulation of collecting duct intercalated 
cells. Annu Rev Physiol 55: 267-288, 1993. 
67. Sebastian A, Sutton JM, Hulter HN, Schambelan M, and Poler SM. 
Effect of mineralocorticoid replacement therapy on renal acid-base 
homeostasis in adrenalectomized patients. Kidney Int 18: 762-773, 1980. 
68. Smith AN, Skaug J, Choate KA, Nayir A, Bakkaloglu A, Ozen S, 
Hulton SA, Sanjad SA, Al-Sabban EA, Lifton RP, Scherer SW, and Karet 
FE. Mutations in ATP6N1B, encoding a new kidney vacuolar proton pump 
116-kD subunit, cause recessive distal renal tubular acidosis with preserved 
hearing. Nat Genet 26: 71-75, 2000. 
47
 
69. Stankovic KM, Brown D, Alper SL, and Adams JC. Localization of 
pH regulating proteins H+ATPase and Cl-/HCO3- exchanger in guinea pig 
inner ear. Hear Res 144: 21-34, 1997. 
70. Stehberger P, Schulz N, Finberg KE, Karet FE, Giebisch G, Lifton 
RP, Geibel JP, and Wagner CA. Localization and regulation of the 
ATP6V0A4 (a4) vacuolar H+-ATPase subunit defective in an inherited form of 
distal renal tubular acidosis. J Am Soc Nephrol 14: 3027-3038, 2003. 
71. Stevens TH and Forgac M. Structure, function and regulation of the 
vacuolar (H+)-ATPase. Ann Rev Cell Dev Biol 13: 779-808, 1997. 
72. Stover EH, Borthwick KJ, Bavalia C, Eady N, Fritz DM, Rungroj N, 
Giersch AB, Morton CC, Axon PR, Akil I, Al-Sabban EA, Baguley DM, 
Bianca S, Bakkaloglu A, Bircan Z, Chauveau D, Clermont MJ, Guala A, 
Hulton SA, Kroes H, Li Volti G, Mir S, Mocan H, Nayir A, Ozen S, 
Rodriguez Soriano J, Sanjad SA, Tasic V, Taylor CM, Topaloglu R, Smith 
AN, and Karet FE. Novel ATP6V1B1 and ATP6V0A4 mutations in autosomal 
recessive distal renal tubular acidosis with new evidence for hearing loss. J 
Med Genet 39: 796-803, 2002. 
73. Teng-umnuay P, Verlander JW, Yuan W, Tisher CC, and Madsen 
KM. Identification of distinct subpopulations of intercalated cells in the mouse 
collecting duct. J Am Soc Nephrol 7: 260-274, 1996. 
74. Trombetta ES, Ebersold M, Garrett W, Pypaert M, and Mellman I. 
Activation of lysosomal function during dendritic cell maturation. Science 299: 
1400-1403, 2003. 
75. Van Hille B, Richener H, Schmid P, Puettner I, Green JR, and Bilbe 
G. Heterogenity of vacuolar H+-ATPase: differential expression of two human 
subunit B isoforms. Biochem J 303: 191-198, 1994. 
76. Verrey F, Hummler E, Schild L, and Rossier B. Control of Na+ 
transport by aldosterone. In: The kidney (3rd ed.), edited by Seldin DW and 
Giebisch G. Philadelphia: Lippincott, 2000, p. 1441-1471. 
77. Wagner CA, Finberg KE, Breton S, Marshansky V, Brown D, and 
Geibel JP. Renal vacuolar H+-ATPase. Physiol Rev 84: 1263-1314, 2004. 
78. Wagner CA, Finberg KE, Stehberger PA, Lifton RP, Giebish GH, 
Aronson PS, and Geibel JP. Regulation of the expression of the Cl-/anion 
exchanger pendrin in mouse kidney by acid-base status. Kidney Int 62: 2109-
2117, 2002. 
79. Wall SM. Recent advances in our understanding of intercalated cells. 
Curr Opin Nephrol Hypertens 14: 480-484, 2005. 
 
48
 
80. Wall SM, Hassell KA, Royaux IE, Green ED, Chang JY, Shipley GL, 
and Verlander JW. Localization of pendrin in mouse kidney. Am J Physiol 
Renal Physiol 284: F229-F241, 2003. 
81. Wang T, Yang CL, Abbiati T, Schultheis PJ, Shull GE, Giebisch G, 
and Aronson PS. Mechanism of proximal tubule bicarbonate absorption in 
NHE3 null mice. Am J Physiol 277: F298-302, 1999. 
82. Wax MB, Saito I, Tenkova T, Krupin T, Becker B, Nelson N, Brown 
D, and Gluck SL. Vacuolar H+-ATPase in ocular ciliary epithelium. Proc Natl 
Acad Sci USA 94: 6752-6757, 1997. 
83. Weinstein AM. A mathematical model of rat cortical collecting duct: 
determinants of the transtubular potassium gradient. Am J Physiol Real 
Physiol 280: F1072-F1092, 2001. 
84. Weinstein AM. A mathematical model of the inner medullary collecting 
duct of the rat: acid/base transport. Am J Physiol 274: F856-F867, 1998. 
85. Weinstein AM. A mathematical model of the outer medullary collecting 
duct of the rat. Am J Physiol Reanal Physiol 279: F24-F45, 2000. 
86. Wingo CS. Active proton secretion and potassium absorption in the 
rabbit outer medullary collecting duct. Functional evidence for proton-
potassium-activated adenosine triphosphatase. J Clin Invest 84: 361-365, 
1989. 
87. Wingo CS, Madsen KM, Smolka A, and Tisher CC. H-K-ATPase 
immunoreactivity in cortical and outer medullary collecting duct. Kidney Int 38: 
985-990, 1990. 
88. Winter C, Schulz N, Giebisch G, Geibel JP, and Wagner CA. 
Nongenomic stimulation of vacuolar H+-ATPases in intercalated renal tubule 
cells by aldosterone. Proc Natl Acad Sci U S A 101: 2636-2641, 2004. 
89. Yamashiro CT, Kane PM, Wolczyk DF, Preston RA, and Stevens 
TH. Role of vacuolar acidification in protein sorting and zymogen activation: a 
genetic analysis of the yeast vacuolar proton-translocating ATPase. Mol Cell 
Biol 10: 3737-3749, 1990. 
 
 
49
 
